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Membrane proteins contribute up to 30% of the proteome and are major targets for 
therapeutics. They transduce signals and transport macromolecules across the 
membrane. The structural information is lacking for most membrane proteins, 
despite that it is required to understand their function and to design appropriate 
drugs that target them, due to the difficulties in crystallization and a limited number 
of experimental tools.  
The topology (2-dimensional structure) of membrane proteins are predicted by 
numerous bioinformatics programs, but it must be validated in vivo. However, the 
eukaryotic system lacks the topology reporter that allows live-cell assessment. In 
this thesis, glycosylatable GFP (gGFP) was developed as a novel topology reporter 
to deduce the topology of membrane proteins in yeast (Saccharomyces cerevisiae) 
and mammalian cells. gGFP was made by introducing a sequon (N-linked 
glycosylation site, N-X-T/S) near the fluorophore. gGFP was non-glycosylated and 
fluorescent in the cytosol, but became glycosylated and non-fluorescent in the ER 
lumen. Hence, the fluorescence and the glycosylation status provide the direct 





Membrane proteins adopt the correct topology during the biogenesis. They are 
inserted into the lipid bilayer through translocon complexes. The key subunits of 
translocon complexes are reported, however, how a translocon recognizes a 
transmembrane segment (TMS), mediates membrane insertion and determine final 
topology is not fully understood. The thesis aimed to understand the mechanism of 
translocon mediated membrane protein insertion at the endoplasmic reticulum (ER) 
and mitochondrial inner membrane (IM). 
The SEC61 complex mediates membrane protein insertion at the ER. When a TMS 
enters the translocon, Sec61 opens laterally towards the lipid bilayer at the 
interface between TMS2 and 7 (lateral gating helices) and allows the partitioning 
of a TMS into the membrane. Previous mutational analysis on Sec61 suggested that 
the insertion process is not a pure thermodynamic event, rather Sec61 is actively 
involved in the insertion process. To provide further insight into the opening and 
closing of Sec61 via the lateral gating helices, a systematic mutagenesis on TMS2 
and 7 was performed in yeast. In the study, two groups of residues that either favor 
the open or closed conformation were identified. Compared to yeast SEC61, 
mammalian SEC61 complex contains additional subunits. To extend the 
investigation to mammalian system by characterizing the roles of different subunits 
of mammalian SEC61, the same set of model signal anchor proteins and multi-
spanning membrane proteins used in the yeast study were expressed in HEK-293T 
and HeLa cells. 
Unlike the SEC61 complex where the lateral gating helices of Sec61 regulate 
membrane protein insertion to the ER, how the TIM23 complex mediates 
membrane protein insertion into the mitochondrial IM remain elusive. Mgr2, a 
subunit of TIM23 complex, was termed as a “lateral gate keeper” as its expression 
level directly affected the insertion of Cyb2-DHFR and Mgm1. To test whether 
Mgr2 acts as a general gate keeper of the TIM23 complex and sets the 
hydrophobicity requirement for protein insertion, model mitochondrial IM proteins 
were expressed. Neither the insertion of other mitochondrial IM proteins nor the 
hydrophobicity requirement was altered at different Mgr2 expression levels. Thus, 




Some mitochondrial IM proteins are inserted into the membrane directly by the 
TIM23 (stop-transfer pathway), whereas the others are sorted to the matrix first and 
inserted from the matrix side (conservative sorting pathway). Detailed 
bioinformatics analysis revealed that conservative sorting proteins tend to carry a 
proline residue in the TMS. To investigate the molecular mechanism of TMS 
recognition by Tim23, with a particular interest in how it discriminates a TMS with 
a proline, a screening scheme was designed and validated for the selection of 
Tim23 with an enhanced tolerance for a proline residue.  
 
 
Keywords: Membrane proteins, topology, GFP, glycosylation, ER, mitochondria, 
translocon, translocase. 
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I.1. Membrane proteins and topology 
I.1.1. Types of membrane proteins 
Membrane proteins constitute about 30% of the proteome and deserves much 
attention as major targets for therapeutics1-3. Membrane proteins are classified into 
two main categories, peripheral and integral membrane proteins. Peripheral 
membrane proteins are associated with the lipid bilayer via an anchoring motif that 
does not span the membrane4,5. In contrast, integral membrane proteins adopt either 
α-helical or β-barrel conformation to be embedded in the hydrophobic lipid bilayer6. 
Integral membrane proteins function as channels or receptors to carry out vital 
cellular processes, namely signal transduction and transport of macromolecules7. At 
the plasma membrane or mitochondrial inner membrane (IM), where cells form a 
boundary from the extracellular space or carries out respiration, respectively, many 
membrane proteins adopt α-helical conformation8. In contrast, β-barrel proteins are 
abundant in bacterial or mitochondrial outer membrane (OM)9. 
I.1.2. Topology of membrane proteins 
α-helical membrane proteins are sorted to different types based on the topology, 
where topology refers to a 2-dimensional structural information of the number of 
transmembrane segments (TMS) and the orientation of soluble loops relative to the 
plane of the membrane10. Single-spanning membrane proteins are classified into 
type I or II based on their location of the N-terminus. Multi-spanning membrane 





Figure 1. Topology of membrane proteins. Single-spanning membrane proteins are 
classified based on the orientation relative to the membrane. Type I proteins have 
the N-terminus in the endoplasmic reticulum (ER) lumen whereas type II proteins 
have the N-terminus in the cytosol. Multi-spanning membrane proteins are 
classified as polytopic. 
 
Membrane proteins must adopt correct topology for their biological function and 
many factors dictate the topology of membrane proteins. Membrane proteins obtain 
their topology during the biogenesis. Firstly, charged residues on a nascent chain 
are key determinants of membrane protein topology. Positively charged residues 
are preferentially positioned at the inside (cytoplasmic side) of the cell for various 
reasons (positive inside rule)12,13. During the protein biogenesis, the exposed 
positively charged residues of a nascent chain may interact with negatively charged 
phospholipid head groups or the translocation machinery may disfavor 
translocation of positively charged residues. The negative membrane potential in 
the cytosolic side of the membrane may also influence retaining positively charged 
residues of a nascent chain14 (Figure 2). Secondly, the components of the 
translocon complexes, which provide a passage for a nascent polypeptide to cross 
or insert themselves into the membrane, influences the orientation of membrane 
proteins15-17. Mutations in the translocon complexes can favor the insertion of 
membrane protein in certain orientation over another orientation18,19. Other factors 
that influence topogenesis of membrane proteins include hydrophobicity, length of 
TMS, and the lipid composition. Hydrophobic, long TMS are preferrably inserted 
in Nout forms and the lipid composition was shown to be the key determinant for 




Figure 2. Some explanations for the positive inside rule. During co-translational 
translocation and membrane insertion from the cis side of the membrane, the 
exposed positively charged residues of a nascent chain may interact with 
negatively charged phospholipid head groups (A) or the translocation machinery 
may disfavor translocation of positively charged residues (B). The negative 
membrane potential in the cytosolic side of the membrane may also influence 




I.1.3. Topology reporters 
Topology reporters are biochemical tags that are fused to or engineered into the 
protein of interest in order to deduce the topology. There are a number of topology 
reporters available for both prokaryotic and eukaryotic systems24. For bacteria, 
green fluorescent protein (GFP) - phosphatase A (PhoA) fusion assay is widely 
used where GFP or PhoA is fused to a membrane protein. Due to the oxidizing 
environment of the periplasmic side, GFP is only fluorescent in the cytosol whereas 
PhoA is only active in the periplamic side25,26. Thus, two systems complement one 
another for a validation of membrane protein topology in bacteria. 
For eukaryotic cells, glycosylation mapping is often used to determine the topology 
of membrane proteins entering the secretory pathway27,28. Glycosylation mapping 
takes an advantage of the spacial specificity of N-linked glycosylation at the 
endoplasmic reticulum (ER) lumen. A protein carrying an amino sequence of N-X-
T/S (sequon, where X can be any amino acid except P) is glycosylated by 
oligosaccaryl transferase (OST) only when the sequon is exposed to the luminal 
side of the ER29,30. Glycosylated status of a sequon is an indicator of ER luminal 
localization whereas non-glycosylated status refers to the cytosolic localization. 
Glycosylation status of a protein is monitored by SDS-PAGE as every glycan 
added to a polypeptide results in a 2kDa increase in the protein mass, slowing 
down the mobility of a protein on a gel. 
Lastly, fluorescence protease protection (FPP) assay is used to solve the protein 
topology of not only the secretory pathway proteins, but also proteins of the other 
subcellular organelles31-33. The assay requires the fusion of a membrane protein 
with a fluorescent protein, followed by a protease digestion and fluorescence 
measurement. The rationale is that if the part of a membrane protein where a 
fluorescent protein is tagged to is exposed to the protease accessible side (outside 
of an organelle or a cell), it would be degraded by the externally added protease, 
resulting in the loss of fluorescence. On the other hand, if the fluorescent protein is 
in the inside of an organelle or a cell, it would be protected from the added protease 




I.2. Protein targeting and insertion into the ER membrane 
I.2.1. Co- and post-translational translocation pathways 
The proteins sorted in the secretory pathway, both soluble and integral membrane 
proteins, are initially targeted to the ER membrane either by co-translational or 
post-translational pathway34,35. In co-translational pathway, once the signal 
sequence emerges from the ribosome, the ribosome nascent chain complex (RNC) 
is recognized by the signal recognition particle (SRP)36. SRP interacts with the SRP 
receptor (SR) at the ER membrane and hand the RNC over to the translocon 
complex37. In post-translational pathway, the proteins are fully synthesized in 
cytosol first prior to the targeting to the ER membrane38. Here, the cytosolic 
chaperones, like Hsp70, maintain the proteins in an unfolded state for the 
translocation across the membrane via the translocon complex39. 
I.2.2. SEC61 translocon complex 
The translocon complex provides a channel for a nascent chain to cross or insert 
into the lipid bilayer (Figure 3). The main component of the ER translocon 
complex is the pore forming Sec6140,41. In yeast, depending on the targeting 
pathways, Sec61 interacts with a specific set of proteins to form distinct translocon 
complexes. Sec61 interacts with Sec62, Sec63, Sec71 and Sec72 to form post-
translational translocon whereas Sec61’s interactions with Sec62, Sec71 and Sec72 
are dispensable for the formation of co-translational translocon42-48. Deletion of 
Sec61, Sec62 or Sec63 is lethal in yeast implying that the proper assembly of the 
translocon complex for the protein translocation and membrane insertion of various 
substrates is essential for cell viability49,50. 
In humans, most secretory proteins take co-translational pathway. Only the small 
secretory proteins, composed of less than 120 residues, are reported to take post-
translational pathway as they are prone to complete the translation prior to the 
recognition by SRP thereby evading co-translational targeting51. The main channel 
Sec61α as well as Sec62 and Sec63 are also present and reported to interact with 
one another in humans52,53.   
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In contrast to the yeast deletion studies, depletion of Sec62 or Sec63 does not affect 
the viability of mammalian tissue-cultured cells54. Here, Sec62 is involved in the 
post-translational transport of small secretory proteins whereas Sec63 plays a role 
in the initial phase of co-translational transport for certain substrates and modulates 
the steady state levels of multi-spanning membrane proteins54,55. There are 
additional components of the translocon complex in humans other than the Sec61, 
Sec62 and Sec63. These include ERj1, TRAP (Translocon associated protein 
complex) and TRAM1 (Translocating chain associating membrane protein 1). ERj1 
is a J-domain containing protein and it can functionally complement Sec63 deletion 
in yeast56. TRAP is required for efficient translocation of secretory proteins with a 
weak signal sequence and it is involved in regulating the positive inside rule15,57. 
TRAM1 participates in an early step of protein transport and regulates the exposure 
of a nascent chain to the cytosol during the biogenesis58-62.  
Both yeast and human share the core channel forming subunit of the translocon, 
Sec6148. It has 10 TMS and opens laterally towards the lipid bilayer to allow the 
partitioning of TMS via its TMS2 and 763,64 (Figure 4). The key residues in 
modulating the gate opening and closing were reported sporadically, however, the 
systematic analysis of all residues lining the gating helices and how they handle 
substrates of different hydrophobicity is not well reported65.  
 
 
Figure 3. Translocation components involved in the membrane protein biogenesis. 
The Sec61/SecY translocon associates with the Sec62-Sec63 complex in yeast, the 
TRAM and TRAP complexes in mammalian cells, and YidC in Escherichia coli 




I.2.3. Determinants of ER membrane protein insertion 
In general, for a TMS to be in the membrane, it needs to take α-helical shape that 
shields the hydrophilic side chains of the amino acids from the hydrophobic lipid 
tails66. Such TMS is recognized by Sec61 and laterally released into the 
membrane67. A typical TMS is composed of about 20 hydrophobic amino acids 
with charged residues being disfavored68. The biological hydrophobicity scale, a 
contribution of individual amino acids in a TMS insertion into the ER membrane, 
was reported with isoleucine being one of the most hydrophobic residue and 
aspartic acid being the most hydrophilic residue69-72.  
Membrane protein insertion process is traditionally viewed as a thermodynamic 
event, but mutational analysis of Sec61 pore region suggest that the translocon not 
only provides a partitioning site, but also plays an active role in TMS insertion63. 
The mutations of the pore ring residues of Sec61 either enhanced or decreased 
membrane protein insertion18. In addition, several mutations in Sec61 were 
reported to affect the topogenesis of membrane proteins19. 
 
 
Figure 4. Sec61 mediates membrane protein insertion. Sec61 opens laterally via 
TMS 2 and 7 to allow partitioning of a TMS into the membrane. Single-spanning 




I.3. Protein targeting and insertion into the mitochondrial IM 
I.3.1. Protein import pathways for mitochondrial proteins 
Majority of mitochondrial proteins are synthesized in the cytosol and are targeted 
to the mitochondria73. The protein targeting to mitochondria was traditionally 
viewed as post-translational event, but there is an accumulating evidence that co-
translational targeting occurs for mitochondrial proteins74. These evidences include 
the identification of OM14 as a ribosome receptor of the OM and ribosomes 
actively translating mitochondrial proteins at the mitochondrial OM by site-specific 
ribosome profiling75,76. 
In either cases, most mitochondrial proteins initially go through the translocase of 
the OM (TOM) complex. Here, the proteins are sorted to four different 
compartments, OM, intermembrane space (IMS), IM and matrix77. OM proteins are 
inserted by TOM/SAM (sorting and assembly machinery) complex78. IMS proteins 
takes either MIA or TIM23 (mitochondrial IMS assembly or translocase of the IM) 
pathway. Proteins taking MIA pathway carries a cysteine motif79. With help from 
small Tim proteins, the disulfide bond formation by Mia40 drives the translocation 
of IMS proteins and prevents the leakage of proteins back to the cytosol80. In 
another case, an IMS protein is targeted to TIM23 complex, processed twice by 
MPP (matrix processing peptidase) and IMP (IM peptidase), and the mature protein 
is released into the IMS81. Carrier proteins with internal sorting signals take TIM22 
pathway for their insertion into the membrane. TIM23 complex mediates the 





I.3.2. TIM23 complex 
TIM23 complex is composed of Tim23, Tim17, Tim50, Tim21, Tim44, Mgr2 and 
associated molecular motors such as mtHsp7083. Tim23 is the pore forming subunit 
of the complex84-86. Whether it forms a pore by itself or in association with Tim17 
is unknown87,88. Both Tim23 and 17 have 4 TMS with their N- and C-terminus in 
the IMS89,90. Tim50 plays a role in presequence recognition91-94. Tim21 along with 
Mgr2 tethers TIM23 to the respiratory chain complex95. The molecular motors, 
mtHsp70, PAM16 and 18 are recruited to the translocase via Tim44 and translocate 
proteins to the matrix96-98. Membrane proteins carrying a presequence are released 
into the membrane by two sorting mechanisms. Some IM proteins are inserted 
directly by TIM23 (Stop-transfer pathway) whereas the others are fully 
translocated to the matrix first and re-inserted into IM from the matrix by other 
proteins such as Oxa183 (Figure 5). Recent studies showed the certain proteins, 
such as Mdl1, utilizes both sorting pathways99,100. Nevertheless, the mechanism of 
channel opening towards the lipid bilayer and the domain of Tim23 or other 
subunits of TIM23 responsible for the lateral insertion of proteins remains largely 
unknown. In addition, how TIM23 distinguishes a stop-transfer TMS and a 
conservative sorting TMS is also elusive. 
 
Figure 5. TIM23 dependent protein sorting pathways. Mitochondrial IM proteins 
of stop-transfer pathway are released into the membrane at the level of TIM23 
whereas those taking the conservative sorting pathway are translocated to the 
matrix and inserted into the membrane afterwards. The TMS of conservative 






I.3.3. Determinants of mitochondrial IM protein insertion 
The biological scale is reported for the TIM23 complex mediated membrane 
protein insertion into the mitochondrial IM101. There is a strong correlation with the 
ER biological scale (R2=0.81), with leucine being the most hydrophobic and 
arginine being the most hydrophilic101. However, the hydrophobicity required for a 
TMS retention in the mitochondrial IM is influenced by the presence of the mAAA 
protease as it actively dislocates a TMS from the mitochondrial IM102. In the 
absence of the mAAA protease, the TIM23 complex is capable of inserting a TMS 
composed of 19 alanines with no leucine that is normally dislocated from the 
membrane by the mAAA protease102. As the TIM23 complex is capable of inserting 
a TMS composed of 19 alanine but bad at inserting TMS with a proline, one 
hypothesis is that TIM23 recognizes α-helical structure rather than the absolute 
hydrophobicity103. However, the protein components responsible for the difference 
in TMS recognition or the component that defines the hydrophobicity required for 
membrane protein insertion into the mitochondrial IM at the level of TIM23 
remained unknown. Recently, Mgr2 was reported to delay the insertion of a model 
mitochondrial IM protein, Cytochrome b2-DHFR (Cyb2-DHFR) and Mgm1104 
(Figure 6). Moreover, in the absence of Mgr2, a protein that lacks the sorting signal 
composed of two positively charged residues, was inserted into the membrane104. 
Thus, Mgr2 was proposed as a lateral gate keeper of the TIM23 complex104. But 
whether Mgr2 acts generally on membrane protein insertion into the mitochondrial 





Figure 6. The schematic diagram of mitochondrial IM protein insertion in the 
presence or absence of Mgr2. If Mgr2 acts as a lateral gate block, the presence of 
Mgr2 would favor the translocation of proteins whereas the absence of Mgr2 would 
favor the insertion of proteins into the membrane. 
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I.4. Aims and experimental approaches 
I.4.1. Development of a glycosylatable GFP as a topology reporter 
The available topology reporters for eukaryotic cells required biochemical 
treatments to cells such as fixation, protease treatment or lysis14. Thus, there was a 
need for a live-cell topology reporter. The goal of the thesis was to develop a 
topology reporter that allows rapid live-cell assessment of membrane protein 
topology in eukaryotes. To develop such topology reporter, GFP was chosen as a 
candidate. GFP has been widely used as a fluorescent probe that allows live-cell 
imaging of protein localization105. Moreover, GFP has been proved as a topology 
reporter in bacterial system where GFP’s fluorescence is lost in the periplasm due 
to the oxidizing environment that disrupts the proper folding of GFP25. Thus, the 
challenge in this study was to design GFP that is fluorescent in the cytosol but 
becomes non-fluorescent in the ER lumen (Figure 7). For this, the ER lumen 
specific protein modification, N-linked glycosylation, was utilized. N-linked 
glycosylation adds 2kDa glycan to a protein which can disrupt the proper folding 
of GFP. N-linked glycosylation sites were engineered at selected sites near the 
fluorophore of GFP. The engineered GFPs were expressed in the cytosol or in the 
ER lumen and the glycosylation and fluorescence profile were assessed106. 
 
Figure 7. The schematic diagram of glycosylatable GFP (gGFP). gGFP is 
unglycosylated and fluorescent in the cytosol but is glycosylated and non-




I.4.2. Membrane protein insertion by Sec61 translocon of yeast and human 
To monitor the membrane protein insertion into the membrane via Sec61 
translocon, model proteins of different characteristics were expressed in both yeast 
and HEK293T. 
The model proteins were based on leader peptidase (Lep) from Escherichia coli69. 
As a model signal anchor protein, the two hydrophobic segments of Lep were 
replaced by 19 amino acids composed of alanines and leucines (Hydrophobic 
segment: H-segment). The H-segment functions as a signal anchor sequence 
(SAS)17. The hydrophobicity of the SAS is controlled by the number of leucines. 
SAS is flanked by N-glycosylation sites, one at the N-terminus and two at the C-
terminus. These sites are only utilized upon exposure to the ER lumen, therefore 
serving as an indicator of membrane protein topology. The addition of glycan at 
each N-glycosylation sites adds about 2kDa to the protein mass, thereby slowing 
protein migration when analyzed by SDS-PAGE. Non-glycosylated product refers 
to non-targeted proteins, singly glycosylated product refers to proteins embedded in 
the membrane with its N-terminus facing the ER lumen, doubly glycosylated 
product refers to proteins embedded in the membrane with its N-terminus in 
cytosol and triply glycosylated product refers to fully translocated proteins107 
(Figure 8). 
 
Figure 8. The schematic representation of a single-spanning model protein, LepH1. 
LepH1 carries a single TMS composed of n leucine and 19-n alanine that is flanked 




To study multi-spanning membrane protein biogenesis, the H-segment was placed 
as the last TMS in 2nd, 3rd and 4th TM positions69,70,108. Here, only the insertion of 
the last TMS was tested as the protein targeting and initial anchoring of the protein 
to the ER membrane occurs by the first TMS of the protein109. The model proteins 
carry N-linked glycosylation sites to distinguish the membrane inserted form and 
non-inserted form. Where indicated, an additional TMS was placed after the H-
segment to study the insertion of a TMS in the middle of multi-spanning membrane 
proteins. 
Few factors governing the membrane protein insertion was tested using Lep model 
proteins. Hydrophobicity is the key factor in protein targeting to the ER membrane 
and subsequent topogenesis110. To investigate the targeting and topogenesis of 
single-spanning membrane protein of various hydrophobicity, LepH1 with H-
segment composed of 1 to 10 leucine was expressed in yeast and mammalian cells. 
In yeast, a marginally hydrophobic segment is targeted by post-translational 
pathway whereas a hydrophobic segment is targeted via co-translational pathway17. 
Thus, the expression of LepH1 in yeast revealed the link between the targeting 
pathway and final topology of the proteins.  
LepH1 was expressed in mammalian cells as well, but it should be noted that 
LepH1 presumably takes co-translational pathway in mammalian cells. Only the 
small secretory proteins of less than 120 amino acids are reported to take post-
translational translocation pathway in mammalian cells51. Thus, the C-terminus of 
LepH1 was truncated to make the overall protein length 120 amino acids to study 
the topogenesis of post-translationally targeted single-spanning membrane proteins 
carrying a TMS of different hydrophobicity in mammalian cells.  
Another factor that influences the membrane protein topogenesis is the C-terminal 
length. A long C-terminal tail that follows a SAS favors the NinCout (NCytosolCER-lumen) 
orientation of a single-spanning membrane protein111. To further test the effect of 
varying C-terminal length of a single-spanning protein in membrane protein 
topogenesis, LepH1 was elongated by the sequence of yeast glycosylatable GFP 
(gGFP). gGFP from yeast is non-fluorescent in mammalian cells, therefore it is 
17 
 
regarded as an extension of 200 amino acids112.  
 
The role of the translocon complex in regulating membrane protein entry to the ER 
was also investigated in yeast107. SEC61 complex was proposed to insert membrane 
proteins via the lateral gating helices of Sec61, but how the gating is regulated 
remained largely questionable. Here, the residues lining yeast Sec61 were 
systematically replaced with an alanine residue one at a time and the effect of the 
mutation in membrane protein insertion and topogenesis were monitored with 




I.4.3. Assessment of Mgr2 in membrane protein insertion via TIM23 complex 
To study whether Mgr2 sets the threshold hydrophobicity required for membrane 
protein insertion into the mitochondrial IM, Mgr2 deletion (mgr2∆), Mgr2 
overexpression (Mgr2↑) and the corresponding wild-type (WT) (YPH499) strains 
were acquired from Dr. Pfanner95,104. To monitor membrane protein insertion and 
translocation in three strains above, a set of Mgm1 based model substrates were 
used. Mgm1 exists in two forms, l-Mgm1 and s-Mgm1113. l-Mgm1 is generated 
when Mgm1’s 1st TMS is inserted into the membrane. s-Mgm1 is generated when 
the 1st TMS is translocated across the membrane, and the 2nd TMS is inserted into 
the membrane. The 2nd TMS carries a rhomboid cleavage site that is processed by 
Pcp1. The cleavage results in the release of s-Mgm1 into the IMS. In WT cells, 
roughly about the same amount of l-Mgm1 and s-Mgm1 exists (Figure 9). 
 
 
Figure 9. The schematics of Mgm1 processing. It contains an N-terminal targeting 
sequence, 2 TMS, and a soluble C-terminal domain. The 1st TMS of Mgm1 is 
sorted into the IM at the level of TIM23 complex to generate l-Mgm1 about 50% of 




Firstly, the effect of Mgr2 deletion or overexpression on the hydrophobicity 
required for membrane protein insertion was monitored using a set of Mgm1 whose 
1st TMS is replaced with 19 amino acid stretch composed of n leucines and 19-n 
alanines (Mgm1-A/L)101. The number of leucine controls the hydrophobicity of the 
1st TMS of Mgm1 where increasing the number of leucine makes the 1st TMS more 
hydrophobic. l-Mgm1 and s-Mgm1 represents membrane inserted and translocated 
Mgm1 respectively, thus the ratio of two isoforms (l-Mgm1 and s-Mgm1) was an 
indicator of membrane protein insertion efficiency. The ratio of l-Mgm1 and s-
Mgm1 was compared between WT, mgr2∆ and Mgr2↑. 
Next, the same screening was done using Mgm1 fusion proteins (MFPs) as Mgm1-
A/L carries a non-native TMS that is dislocated from the mitochondrial IM by the 
mAAA protease114. The screening with mAAA independent MFPs was required to 
rule out the effect of the mAAA protease. MFPs contain the N-terminal domain of 
mitochondrial IM proteins of the stop-transfer pathway or the conservative sorting 
pathway fused to the C-terminal domain of Mgm1. 
The 1st TMS of MFPs cover a broad range of hydrophobicity (ΔGapp). MFPs based 
on the proteins taking the stop-transfer pathway tend to be more hydrophobic 
compared to the ones taking the conservative pathway. Like Mgm1-A/L, the ratio 
of l-MFP and s-Mgm1 was compared to monitor membrane insertion and 
translocation. Lastly, the role of Mgr2 in recognizing the charged residues flanking 
a TMS was tested with Mgm1 mutants. Mgr2 permits the entry of Cyb2 with 
defective sorting signal where two positively charged residues preceding the TMS 
were mutated104. Mgm1 also has many charged residues that precedes or follows 
the 1st TMS115. These residues were mutated to alanine or to opposite charged 
residues and the insertion of these charged residue mutants in Mgr2 deletion or 




I.4.4. Screening for Tim23 with enhanced proline tolerance 
To identify the domain of Tim23 that mediates the recognition and insertion of a 
TMS, both random and systematic mutagenesis screening was designed. The 
selection scheme utilizes a chimeric model protein made of Cyb2 and cytochrome c 
heme lyase (CCHL) and tim23Δcyc3Δ strain. 
Cyb2 is an IMS protein. It is first targeted to matrix via its N-terminal presequence 
which is removed by the MPP upon its exposure, generating i-Cyb2. i-Cyb2 is 
inserted into the IM and cleaved once again by IMP, releasing the mature Cyb2 (m-
Cyb2) into IMS116. When alanine 63 (A63) is mutated to proline (P), Cyb2 is no 
longer sorted into the IM, instead it is translocated to matrix (Figure 10). By taking 
advantage of differential targeting of Cyb2, mature CCHL was fused to WT 
preCyb2(167) and preCyb2(167) with A63P mutation. preCyb2(167)-CCHL is 
inserted into membrane, whereas preCyb2(A63P-167)-CCHL is translocated to the 
matrix. CCHL is encoded by Cyc3 gene in Saccharomyces cerevisiae and adds 
heme to apo-cytochrome c117. CCHL is required at the IMS for cell survival on 
non-fermentable carbon source118. Thus, the expression of preCyb2(167)-CCHL in 
cyc3Δ rescues the growth defect on non-fermentable carbon source whereas 
preCyb2 (A63P-167)-CCHL does not. 
 
Figure 10. The sorting of preCyb2-CCHL and preCyb2(A63P)-CCHL. Cyb2 is 
sorted into the mitochondrial IM by TIM23. However, alanine to proline mutation 
at position 63 causes the translocation of the protein into the matrix.   
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tim23Δcyc3Δ strain with WT TIM23 in Ura plasmid and preCyb2(A63P-167)-
CCHL is viable only on fermentable carbon source. But if preCyb2 (A63P-167)-
CCHL could be inserted into the IM and processed by IMP, it would support the 
cell growth on non-fermentable carbon source. As membrane insertion of Cyb2 is 
mediated by TIM23 complex, TIM23 was randomly mutagenized and introduced 
into tim23Δcyc3Δ expressing preCyb2(A63P-167)-CCHL. A plasmid encoding WT 
TIM23 was removed by plasmid shuffling. Any colony formed after the selection 
on non-fermentable medium is a probable candidate exhibiting enhanced 
membrane insertion by Tim23 (Figure 11). Tim23 mutant capable of supporting the 
cell growth of tim23Δcyc3Δ strain expressing preCyb2(A63P-167)-CCHL will be 
isolated and sequenced. Once the mutations are identified, it will be retransformed 
into tim23Δcyc3Δ strain with a set of model proteins to validate enhanced 
membrane protein insertion activity by Tim23. 
 
Figure 11. The selection scheme for Tim23 with enhanced membrane insertion 
activity. CCHL, encoded by CYC3 gene and required for cell growth in non-
fermentable carbon source, was fused to the C-terminus of preCyb2(A63P). WT 
Tim23 translocates the fusion protein preCyb2(A63P)-CCHL to the matrix, 
therefore is expected to have no influence on the growth of cyc3∆ on non-
fermentable carbon source. However, if a mutant Tim23 could insert the fusion 
protein into the IM, then CCHL would be exposed to the IMS and thus supports the 
cell growth on non-fermentable carbon source.  
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I.1.5. Quantitative analysis of protein import kinetics and forces 
Quantitative information such as protein import kinetics or forces acting on 
preproteins during the import process is lacking for mitochondrial proteins. To 
quantitatively analyze the mitochondrial protein import process, an optical tweezer 
analysis was designed where an isolated mitochondria and a purified preprotein 
would be attached to different beads for kinetic and force measurements during the 
import process. Optical tweezer enables the measurement of protein import kinetics 
by monitoring the displacement of the bead that the substrate is attached to during 
the protein import at a very fine scale119. Protein import force is also measured by 
applying a pulling force in the opposite direction of the import, and the minimum 
force at which the import is blocked is representative of the protein import force120.  
For this, mitochondria expressing Mcr1-Avi tag will be isolated from yeast grown 
in non-fermentable carbon source. Mcr1 is an OM protein with its C-terminus 
exposed to the cytosol121. Biotin acceptor site, Avi tag, will be fused to the C-
terminus of the Mcr1 to allow efficient biotinylation of mitochondria in the 
presence of BirA (Biotin ligase)122. The mitochondria will be biotinylated prior to 
isolation (in vivo biotinylation) or after isolation (in vitro biotinylation) and 
attached to the streptavidin coated beads123. 
Mitochondrial expressing Mcr1-Halotag will also be prepared as an alternative 
approach to prepare for cases of inefficient in vivo/in vitro biotinylation. Halotag 
interacts specifically with a set of Halo-ligands124. For the attachment of 
mitochondria expressing Mcr1-Halotag to the bead, streptavidin beads coated with 
biotinylated Halo-ligand will be used. The interaction between the Haloligand and 
Halotag will firmly hold mitochondria onto the bead. 
The substrate preprotein, Cox5a will be expressed in Escherichia coli and purified. 
Purified Cox5a carries ybbR tag at the C-terminus as a CoA acceptor site. CoA-
DNA will be attached to ybbR tag by Sfp125. The 3kb long linker DNA with 5’ 
digoxigenin will be ligated to CoA-DNA, and the ligated product DNA linker-
Cox5a will be fused to anti-digoxigenin coated polysterene beads for analysis120. 
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The two beads, mitochondria attached bead and Cox5a attached bead, will be 
trapped in a laser beam and will be placed in close proximity to allow protein 
import. The import kinetics will be monitored by the displacement of the bead that 
Cox5a is attached to. The force loaded (the force that acts in the opposite direction 
of the import) will be changed to measure the protein import force. 
 
 
Figure 12. The experimental setup for optical tweezer analysis. Isolated 
mitochondria is biotinylated by BirA either in vivo or in vitro using Mcr1 with Avi 
tag as a biotin acceptor protein present in the OM. The mitochondria is attached to 
the streptavidin coated bead via biotin-streptavidin interaction. Cox5a-ybbR tag is 
expressed in Escherichia coli in the presence of CoA-DNA conjugate. Sfp adds 
CoA-DNA to ybbR tag and Cox5a with CoA-DNA will be purified. 3kb long DNA 
linker is amplified by PCR with 5’ digoxigenin modified primer and ligated to 
Cox5a with CoA-DNA. The ligated product is attached to polysterene beads coated 

















II.1. Yeast and mammalian cell culture 
II.1.1. Glycosylatable GFP study 
gGFP constructs in p424GPD vectors were transformed into W303-1α (MATα, 
ade2, can1, his3, leu2, trp1, ura3) and grown in -Trp medium at 30° C overnight106. 
Mammalian cells (HeLa or HEK-293T) were grown in medium (10% FBS in 
DMEM with antibiotics) at 37° C with 5% CO2. Cells were transiently transfected 
with plasmids using Attractene (Qiagen) following the manufacturer’s protocol112. 
II.1.2. Sec translocon study 
sec61Δ strain (MATα, ura3-1, leu2-3,112, his3-11,15, trp1-1, ade2-1, can1-100, 
sec61::HIS3 [pH6-Sec61-YCplac33]) was transformed with pDQ1 encoding the 
WT SEC61 gene or mutant sec61126,127. pH6-Sec61-YCplac33 that contains WT 
SEC61 gene was removed by FoA (5-fluoroorotic acid) selection. The plasmids 
encoding model proteins were transformed into the FoA selected strains and the 
cells were cultured in -Leu-Trp medium at 30° C overnight unless stated107. 
Mammalian cells were handled as describes in M.1.1. HiperFect (Qiagen) was used 
for the transfection of siRNAs. 
II.1.3. Mgr2 study 
Mgm1 and MFP constructs encoded in pHP84HA vector were transformed into 
YPH499 (MATa, ade2, lys2, his3, leu2, trp1, ura3), mgr2Δ (YPH499 
mgr2::KANMX6) and Mgr2↑ (mgr2Δ [pPGKMGR2]) for Mgr2 characterization104. 
The cells were cultured in -Leu or -Leu-Ura medium at 30° C or 39° C overnight. 
For respiratory growth, yeast cells were cultured in appropriate medium with 3% 




II.1.4. Tim23 random mutagenesis study 
pHP84 vectors encoding CYC3, CYC3-HA, Cyb2-CCHL-HA or Cyb2(A63P)-
CCHL-HA were transformed into BWY4741(MATa, his3, leu2, met15, ura3), 
cyc3Δ (BWY4741, cyc3::KANMX6), W303-1α and cyc3Δtim23Δ (W303-1α, 
cyc3::KANMX6, tim23::HIS3 [pRS316-TIM23]). The transformants were selected 
on -Leu at 30° C and were streaked on YPEG plate for the growth assay 30° C. 
II.2. Proteasome inhibition assay 
Six hours after transfection, the proteasome inhibitor, MG132 was added to the 
cells together with fresh media at a concentration of 10μM in dimethyl sulfoxide 
(DMSO). Equal amount of DMSO was added to control populations112. 
II.3. Protein preparation, SDS-PAGE and Western blotting 
Yeast transformants were grown overnight at 30° C. Whole-cell lysates were 
prepared as previously described128. Lysates were incubated with or without 
endoglycosidase H (Endo H) (Roche) for 2 h at 37° C to remove N-linked 
oligosaccharides. SDS–PAGE and Western blot analysis with an anti-HA antibody 
were followed. Western blots were developed with Amersham Bioscience 
Advanced ECL kit on a Biorad Chemi-doc-XRS+ system (Biorad)106. 
For mammalian cells, lysates of were prepared using lysis buffer (1% NP-40 in 1X 
PBS with Protease Inhibitors). Endo H treatment (Roche), SDS-PAGE and Western 
blot analysis were performed as described previously. Horseradish peroxidase 
(HRP) conjugated GFP antibody (Rockland) was used to detect GFP and GFP 




II.4. Pulse (Chase) labeling, immuno-precipitation and autoradiography 
Pulse(Chase) labeling of yeast transformants, immuno-precipitation and 
autoradiography were done as described in Jung et al16. Mammalian cells 
transfected with plasmids encoding model proteins were cultured to 90% 
confluency in 60mm dish. The cells were washed twice with 1X PBS and 
incubated in -Met-Cys medium for 45 min. 10μl of S35 Met-Cys was added and the 
cells were further incubated for 20 min. The cells were collected in 1.5ml tube with 
lysis buffer (1% NP-40 in 1X PBS with Protease Inhibitors) and subjected to 
immuno-precipitation.  
II.5. Optical tweezer based in vitro protein import assay 
II.5.1. Mitochondria isolation and in vitro protein import assay 
The isolation of mitochondria will be performed as decribed in Weckbecker et al129. 
The isolated mitochondria will be biotinylated in vivo or in vitro following van 
Werven et al or manufacturer’s protocol (Avidity) respectively123. The preparation 
of the substrate protein, Cox5a, and the optical tweezer analysis will be done as 
described in Maillard et al120. In brief, yeast cells will be cultured in semi-lactate 
medium to enrich mitochondria prior to isolation. For in vivo biotinylation, yeast 
transformants co-expressing Mcr1-Avi and BirA will be used and biotin will be 
added to the culture medium. For in vitro biotinylation, isolated mitochondria 
expressing Mcr1-Avi will be mixed with purified BirA in the presence of biotin. 
The biotinylated status of mitochondria will be checked by streptavidin shift assay 
as well as western blotting against biotin123. 
II.5.2. List of constructs made for in vitro protein import assay  
Up to date, the materials required for an optical tweezer based in vitro protein 
import assay were prepared. To produce biotinylated mitochondria, mitochondria 
was isolated from W303-1α expressing Mcr1-HA-Avi. Isolated mitochondria was 
incubated with purified BirA in the presence of biotin for biotinylation of Avi tag. 
The substrate mitochondrial proteins, Cox5a and preCyb2-GFP, were expressed in 




II.6. Fluorescence microscopy 
Yeast transformants expressing gGFP fusion constructs were grown overnight in 
5ml of -Trp medium at 30° C. 100μl of cells were taken from 0.7 OD600 culture. 
Cells were transferred to a 96well plate for fluorescence assessment using a Zeiss 
Axiovert 200M inverted microscope with a Plan-NeoFluar 100/1.30 NA oil-
immersion objective lens. Fluorescence images were taken as described in Sung et 
al., using a standard fluoresceinisothiocyanate (FITC) filter set (excitation band 
pass filter, 450-490nm; beam splitter, 510nm; emission band pass filter, 515-
565nm). The pictures were taken with an exposure time of 0.2 ms106. For HEK-
293T or HeLa cells, transiently transfected cells were assessed under JuLi 
fluorescence cell imager (Digital Bio) for fluorescence measurement. Where 
indicated, cells were cultured on a cover glass for direct imaging on Axioimager 
A1112.  
II.7. Fluorescence measurements 
Yeast transformants expressing gGFP fusion constructs were grown in 10 ml of -
Trp medium at 30℃ overnight. Cells were harvested at 0.3-0.6 OD600 by 
centrifugation at 3,000g and resuspended in 200μl of YSB buffer (50mM Tris–HCl, 
pH 7.6, 5mM EDTA, pH 8, 10% (w/v) Glycerol and 1X Protease Inhibitor Cocktail. 
Cells were transferred to a 96-well microplate (Nunc) and the fluorescence 
measurements were taken on Perkin Elmer Envision 2102 Multilabel reader with 
excitation band pass filter at 460nm and cut-off FITC filter at 535nm. All 
fluorescence measurements were subtracted by fluorescence from whole-cell 
lysates of yeast transformants carrying an empty vector. Averages of at least three 
independent measurements were plotted with standard errors106. For HEK-293T or 
HeLa cells, transiently transfected cells were washed with 1X PBS and collected 
by trypsin-EDTA treatment. The collected cells were resuspended in 3.7% 
















III.1. gGFP as a novel membrane protein topology reporter. 
III.1.1. Engineering of gGFP for Saccharomyces cerevisiae 
The rationale behind the design of gGFP was the assumption that the presence of 
an N-linked glycan near the GFP fluorophore might interfere with protein folding 
and maturation of the fluorophore, rendering the protein non-fluorescent. Based on 
the X-ray structure of GFP, two asparagine residues at positions 121 and 170 
(N121 and N170) near the fluorophore were initially chosen130 (Figure 13A). To 
introduce an N-linked glycosylation acceptor site, asparagine-X-threonine-Y 
(where X, Y can be any amino acid except proline), isoleucine 123 (I123) and 
glutamic acid 172 (E172), two residues downstream of the asparagine residues at 
positions 121 and 170, were individually changed to threonine in yeast enhanced 
GFP (yEGFP)131. To facilitate detection by Western blotting and immuno-
fluorescence, a hemagglutinin (HA) tag was introduced directly upstream of GFP 
(Figure 13B). GFP fluorescence was abolished when isoleucine123 was changed to 
threonine. 
To obtain a version of gGFP that is localized to the lumen of the ER, the signal 
peptide (SP) from invertase was fused to the N terminus of GFP (Figure 13B). 
Three constructs each carrying GFP, GFP(E172T) or SP-GFP(E172T) were 
transformed into the Saccharomyces cerevisiae strain W303-1a. Whole-cell lysates 
were prepared and fluorescence was measured. While fluorescence of GFP(E172T) 
was comparable to that of WT GFP, fluorescence of SP-GFP(E172T) was not 
significantly different from the whole-cell lysate prepared from a yeast 
transformant carrying an empty vector (Figure 13C). The version of GFP used in 
the study, yEGFP, in itself has much lower fluorescence when localized to the 
lumen of the ER131. When comparing the fluorescence of SP-GFP and SP-
GFP(E172T), approximately a twofold reduction in fluorescence for SP-
GFP(E172T) was observed (Figure 13C inset). Hence, the addition of the glycan 
moiety reduces the residual fluorescence of lumenally located SP-GFP(E172T) to 




To further determine whether SP-GFP(E172T) was translocated to the lumen of the 
ER, whole-cell lysates were treated with Endo H for removal of N-glycans, 
followed by SDS-PAGE and Western blotting. The sample treated with Endo H 
showed faster migration on the Western blot, indicating that GFP(E172T) was 
glycosylated, and thus correctly translocated to the lumen of the ER (Figure 13D). 
Next, fluorescence from the cells expressing either GFP(E172T) or SP-GFP(E172T) 
was assessed by fluorescence microscopy. Only the cells expressing GFP(E172T), 
the cytosolically localized construct, exhibited a detectable fluorescence signal 
(Figure 13E). These results demonstrate that GFP(E172T) is unglycosylated and 
fluorescent in the cytosol but is glycosylated and non-fluorescent when localized in 





Figure 13. Engineering a gGFP. (A) Structure of yEGFP (PDB 3AI4)132. The red 
label indicates the N170 residue that becomes glycosylated in gGFP. (B) Schematic 
representation of GFP constructs. The glycosylation site is labeled as Y. HA 
denotes a triple hemagglutinin tag. The sequence of the invertase SP is shown. (C) 
Fluorescence measurements. Whole-cell lysates were prepared from yeast 
transformants expressing GFP, GFP(E172T), SP-GFP or SP-GFP(E172T). 
Fluorescence was measured with a 460 nm excitation and 535 nm cut-off filter, and 
relative fluorescence units were normalized by subtracting the values from the 
whole-cell lysate of a yeast transformant carrying an empty vector. Averages of at 
least three independent measurements are shown with standard errors. In the inset, 
GFP fluorescence of SP-GFP and SP-GFP(E172T) is compared. (D) SP-
GFP(E172T) is glycosylated. Whole-cell lysates prepared from yeast transformants 
expressing GFP(E172T) or SP-GFP(E172T) were subjected to Endo H digestion, 
SDS–PAGE, and Western blot analysis. ● denotes a glycosylated form, ○ denotes a 
non-glycosylated form. ∗indicates an uncharacterized background band. (E) 
Fluorescence microscopy of yeast cells expressing GFP(E172T) or SP-






For large membrane proteins, the difference in molecular weight between the 
presence and absence of a single N-linked glycan (2 kDa) in gGFP might be too 
small to be detected on SDS-gels. To overcome this difficulty, an additional 
glycosylation site was engineered at positions 7 or 228 in gGFP, or in HA tag. The 
positions of these sites were chosen such that they would least disrupt folding and 
maturation of the fluorophore.  
To test the efficiency of N-linked glycosylation at the three sites, whole-cell lysates 
of yeast transformants expressing GFP(L7N/E172T), GFP(E172T/G228N), 
GFP(HAg/E172T), SP-GFP(L7N/E172T), SP-GFP(E172T/G228N), or SP-
GFP(HAg/E172T) were prepared and subjected to Endo H digestion. SP-
GFP(E172T/G228N) and SP-GFP(HAg/E172T) were efficiently glycosylated on 
both sites (Figure 14A). In comparison, N7 in SP-GFP(L7N/E172T) did not get 
efficiently glycosylated as about equal amounts of singly and doubly glycosylated 
proteins were apparent. Whole-cell lysates from yeast transformants expressing 
these constructs were then tested for fluorescence. GFP(E172T/G228N) did not 
fluoresce, whereas GFP(L7N/E172T) and GFP(HAg/E172T) showed comparable 
levels of fluorescence as GFP(E172T) (Figure 14B). Since the additional 
glycosylation site was efficiently glycosylated and the fluorescence pattern of 
gGFP was maintained in GFP(HAg/E172T), this version of gGFP can be used to 





Figure 14. Engineering an additional glycosylation site into gGFP. (A) gGFP with 
an additional glycosylation site can be doubly glycosylated. Endo H digestion 
analysis of yeast transformants expressing SP-GFP(E172T), SP-GFP(L7N/E172T), 
SP-GFP(E172T/G228N) or SP-GFP(HAg/E172T). GFP(E172T), 
GFP(L7N/E172T), GFP(E172T/G228N) and GFP(HAg/E172T) were loaded as 
controls for an unglycosylated gGFP. ●● indicates a doubly glycosylated form, ● 
indicates a singly glycosylated form, ○ indicates a non-glycosylated form. (B) 
Fluorescence measurements. Fluorescence was measured as described in Figure 
12C. Averages of two measurements are shown except for GFP(E172T). Average 




III.1.2. Validation of gGFP as a topology reporter 
To test whether gGFP can be used as a topology reporter, gGFP was fused to the C 
terminus of two membrane protein constructs based on Lep protein from 
Escherichia coli, an IM protein with two TMS (TMS1, TMS2) near the N 
terminus133. In these constructs, TMS2 was replaced by two different 19-residue 
long segments; one composed of polar residues that does not insert into the IM 
(construct Lep-Cin-gGFP) and the other composed of a very hydrophobic 6 L/13A 
segment that is known to insert efficiently into the ER membrane (Lep-Cout-
gGFP)69 (Figure 15A). Whole-cell lysates from yeast transformants expressing 
Lep-Cin-gGFP exhibited high fluorescence, whereas Lep-Cout-gGFP transformants 
showed only weak fluorescence (Figure 15B). 
Next, to assess the glycosylation status of the two constructs, whole-cell lysates 
from yeast transformants expressing either Lep-Cin-gGFP or Lep-Cout-gGFP were 
prepared and treated with Endo H. Two glycan acceptor sites are present in the Lep 
part, one in the lumenally located N-terminal tail and the other just downstream of 
the P or H segment, hence molecules with a single glycan (1G) have an Nout-Cin 
membrane topology, whereas triply glycosylated molecules (3G) have an Nout-Cout 
orientation (Figure 15A). As expected, Lep-Cin-gGFP was singly glycosylated and 
Lep-Cout-gGFP was triply glycosylated (Figure 15C). A cleaved and glycosylated 
form of Lep-Cout-gGFP was also detected. Previously, it was shown that this form 
is generated by signal peptidase cleavage in the 6L/13A segment, releasing the C-
terminal domain of the protein to the lumen. These results demonstrate that gGFP 
fusion neither interferes with correct protein targeting nor with the membrane 




Figure 15. gGFP can be used as a membrane topology reporter. (A) Schematic 
representation of model proteins, Lep-Cin and Lep-Cout
69. The glycosylated sites are 
labeled as Y. TM1 indicates TM segment 1 of Escherichia coli Lep, P stands for a 
polar segment, and H stands for a hydrophobic segment133. (B) Fluorescence 
measurements. Whole-cell lysates were prepared from yeast transformants 
expressing Lep-Cin-gGFP or Lep-Cout-gGFP. Fluorescence was measured as 
in Figure 12C. (C) Endo H digestion analysis of yeast transformants expressing 
Lep-Cin-gGFP or Lep-Cout-gGFP. ●●● indicates a triply glycosylated form, ● 
indicates a singly glycosylated form, ○ indicates a non-glycosylated form, 




III.1.3. Development of gGFP for mammalian cell culture. 
To test the applicability of yeast gGFP in mammalian cells, yeast gGFP was cloned 
into pcDNA3.1 and transfected into HeLa cells. However, yeast gGFP was not 
expressed in HeLa cells, which may have been due to the differences in codon 
usage between yeast and mammalian systems. 
To overcome problems in gGFP expression in HeLa cells, pEGFP-N1 plasmid 
encoding mammalian EGFP was used to introduce a glycosylation site by 
engineering an E173T substitution (equivalent to E172T in yEGFP, which was 
reported to abolish fluorescence upon N-linked glycosylation)106 (Figure 16A). 
Mammalian EGFP contains an additional valine residue at position 2 compared to 
yEGFP, thus the residue number is one higher for mammalian EGFP.  
To check whether the engineered N-linked glycosylation site (N171- I172-T173) is 
utilized in the ER lumen, the cleavable SP of secreted yeast invertase was fused to 
EGFP variants at their N-terminus for translocation into the ER lumen. Previously, 
SP of yeast invertase was shown to be functional in mammalian cells134. In addition, 
the ER retention signal, KDEL sequence, was added to the C-terminus to prevent a 
gGFP fusion protein from being secreted135 (Figure 16B). The plasmid encoding 
EGFP(WT) or EGFP(E173T) with or without the SP was transfected into HEK-
293T cells and their fluorescence pattern was examined by fluorescence 
microscopy and FACS analysis. Both EGFP(WT) and EGFP(E173T) exhibited 
fluorescence in the cytosol (Figure 16C, D). The fluorescence from EGFP(E173T) 
was more intense compared to that of the WT EGFP. SP-EGFP(E173T) fluoresced 
in the ER lumen, indicating that the E173T mutation alone did not abolish 




A study by Losfeld et al reported another version of gGFP that was developed for 
clinical use136. This version of GFP carries an engineered N-linked glycosylation 
site at position 145. Once this site is glycosylated, GFP loses fluorescence in 
mammalian cells. Therefore, we prepared EGFP(WT) with two N-linked 
glycosylation sites, N145 and N171, by introducing an N147T substitution in 
EGFP(E173T) (Figure 16A). With two N-linked glycosylation sites in the EGFP 
sequence, the size difference between glycosylated and unglycosylated EGFP 
would be more prominent, thus enhance the applicability as a potential membrane 
topology reporter when fused to larger membrane proteins.  
The protein EGFP(N147T/E173T) was tested for fluorescence and glycosylation 
patterns. EGFP(N147T/E173T) exhibited fluorescence in the cytosol whereas its 
ER version, SP-EGFP(N147T/E173T), showed no fluorescence under a 
fluorescence microscopy (Figure 16C). FACS analysis offered more detailed 
fluorescence measurements of EGFP variants (Figure 16D). Mean fluorescence 
was reduced in SP-EGFP(N147T/E173T) compared to the cytosolic version but we 
noticed a significant difference in maximum fluorescence between the cytosolic 
and the ER version of EGFP(N147T/E173T), as well as between detectable and 
non-detectable fluorescent EGFP variants under fluorescence microscopy (Figure 
16C, D). While mean fluorescence may differ depending on protein concentration, 
maximum fluorescence may more accurately indicate changes in fluorescence 
intensity due to N-linked glycosylation, thus more reliable to assess glycosylation-
dependent fluorescence changes of gGFP. Endo H digestion of whole-cell lysates 
showed that SP-EGFP(N147T/E173T) was efficiently glycosylated in the ER 
lumen (Figure 16E). As EGFP(N147T/E173T) exhibits the characteristics of yeast 
gGFP whose fluorescence is selectively lost only upon glycosylation in the ER 




Figure 16. gGFP for mammalian cells. (A) The structure of EGFP 
(PDB 2Y0G) with engineered glycosylation sites, N145 and N171, marked in 
red137. (B) gGFP constructs. SP denotes a cleavable signal peptide (SP) of an 
invertase and KDEL is the ER retention sequence. The engineered glycosylation 
sites are labelled with Ys. (C) Fluorescence microscopy of HEK-293T cells 
expressing EGFP(WT), EGFP(E173T), EGFP(N147T/E173T) in the cytosol and 
SP-EGFP, SP-EGFP(E173T) or SP-EGFP(N147T/E173T) in the ER. Cells were 
viewed with a GFP filter for GFP fluorescence after 24 h of transfection under Juli 
cell imager. (D) The cells were analyzed by FACS Canto. Mean (top) and 
maximum (bottom) fluorescence of EGFP(WT), EGFP(E173T), 
EGFP(N147T/E173T), SP-EGFP, SP-EGFP(E173T) or SP-EGFP(N147T/E173T) 
are plotted with standard deviations. (E) SP-EGFP(N147T/E173T) is efficiently 
glycosylated. Whole-cell lysates prepared from HEK-293 cells expressing 
EGFP(WT), EGFP(E173T), EGFP(N147T/E173T), SP-EGFP, SP-EGFP(E173T) 
or SP-EGFP(N147T/E173T) were subjected to Endo H digestion, SDS–PAGE and 
Western blot analysis. ●● Denotes doubly glycosylated, ● singly glycosylated and 







To validate the applicability of mammalian gGFP as a membrane protein topology 
reporter, gGFP was fused to a set of model membrane proteins derived from 
Escherichia coli Lep of known membrane topology. The derived Lep variant 
(LepH3) contains 3 TMS, where the last TMS is the test segment of varying 
hydrophobicity made of leucines and alanines (H-segment)70. It has N-linked 
acceptor at two sites; in loop 2 and in the C-terminus (Figure 17A). LepH3 with 3 
leucines and 16 alanines in the test segment (LepH3-Cout) is expected to have its C-
terminus translocated to the ER lumen whereas LepH3 with 19 leucines (LepH3-
Cin) is expected to have its test segment inserted into the membrane, thereby 
leaving its C-terminus in the cytosol.  
The gGFP was fused to the C-terminus of LepH3-Cout and LepH3-Cin, then 
expressed in HEK-293T cells. When the fusion proteins were expressed in HEK-
293T cells, LepH3-Cin-gGFP was fluorescent whereas LepH3-Cout-gGFP was not 
(Figure 17B, C). Endo H digestion of lysates confirmed that the C-terminus of 
LepH3-Cin-gGFP remained in the cytosol whereas that of LepH3-Cout-gGFP was 
translocated to the ER lumen (Figure 17D). In sum, these results demonstrate that 





Figure 17. gGFP fused to model membrane proteins. (A) Schematics of LepH3-
Cout-gGFP and LepH3-Cin-gGFP in the ER membrane. Glycosylation sites are 
marked with Ys. Utilized glycosylation sites are colored in black and unutilized 
sites are colored in grey. (B) Fluorescence microscopy of HEK-293T cells 
expressing Lep-H3-Cout-gGFP and Lep-H3-Cin-gGFP. Cells were viewed with a 
GFP filter for GFP fluorescence after 24 h of transfection under Juli cell imager. 
Brightness and contrast were adjusted for clearer pictures. (C) Mean (left) and 
maximum (right) fluorescence of LepH3-Cout-gGFP and LepH3-Cin-gGFP. The 
cells were analyzed by FACS Canto and the average of two independent 
measurements is plotted. (D) Whole-cell lysates prepared from HEK-293T cells 
expressing LepH3-Cout-gGFP or LepH3-Cin-gGFP were subjected to Endo H 
digestion, SDS-PAGE and Western blot analysis. ●●●● Denotes quadruply 
glycosylated (Cout), ● singly glycosylated (Cin) and ○ non-glycosylated form. M 




III.1.4. Topology assessment of disease related proteins by gGFP 
Mammalian gGFP was tagged to the C-terminus of Up-Regulated Gene 7 (URG7), 
Multi-drug Resistance Protein 6 (MRP6102), SP-C(Val) and SP-C(Leu) to assay 
their orientation in HEK-293T cells (Figure 18A). Three out of four test proteins, 
MRP6102, SP-C(Val) and SP-C(Leu), exhibited no fluorescence (Figure 18B, C). 
Endo H digestion analysis revealed that the proteins were efficiently glycosylated, 
thereby assaying the fusion joint (the localization of gGFP) to the ER lumen 
(Figure 18D). In contrast, URG7 exhibited fluorescence, suggesting that its C-
terminus is located in the cytosol (Figure 18B, C). The C-terminus of URG7 can 
reside in the cytosol in two different forms, untargeted and membrane inserted 
form in an Nout/Cin orientation. Endo H digestion of URG7 lysate showed that both 
glycosylated and unglycosylated forms are present in vivo (Figure 18D). Hence, it 
is concluded that URG7 targeting in vivo is not efficient, leaving about 50% in the 
cytosol, but once targeted, it is oriented with an Nout/Cin orientation. 
In contrast to our gGFP study of SP-C where the protein is inserted in an Nin/Cout 
form, the in vitro topology study with microsomes revealed that SP-C is embedded 
in the membrane in two different orientations (unpublished data). To test whether 
the discrepancy between the results from two systems arises from the presence or 
absence of the quality control system, HEK-293T cells were treated with 
proteasome inhibitor MG132. While the majority of SP-C was inserted into the 
membrane in an Nin/Cout form, the unglycosylated SP-C was also detected in the 
presence of MG132 (Figure 19A). These results suggest that SP-C is either inserted 
in two different membrane orientations or some were not targeted to the membrane, 
and the cells remove the incorrectly inserted, Nout/Cin form, or an untargeted form 
by the proteasome in vivo.  
To distinguish these two possibilities, an additional N-linked glycosylation site was 
engineered at the N-terminus of SP-C and the protein was expressed in HEK-293T 
cells. If the unglycosylated SP-C was incorrectly inserted as Nout/Cin form, with an 
N-linked glycosylation site at the N-terminus, it would be glycosylated. However, 
unglycosylated product was still detected, thus suggesting that a small fraction of 




Figure 18. In vivo topology assessment of URG7, MRP6102, SP-C(Val) and SP-
C(Leu). (A) Schematics of URG7, MRP6102, SP-C(Val) and SP-C(Leu) with gGFP 
tag in the ER membrane. The TMS sequences of SP-C(Val) and SP-C(Leu) are 
shown. (B) Fluorescence microscopy of HEK-293T cells expressing URG7-gGFP, 
MRP6102-gGFP, SP-C(Leu)-gGFP and SP-C(Val)-gGFP. Cells were viewed as 
described in Figure 16B. (C) Mean (top) and maximum (bottom) fluorescence of 
URG7, MRP6102, SP-C(Val) and SP-C(Leu) with gGFP. The cells were analyzed by 
FACS Canto and the average of three independent measurements plus the standard 
deviations is shown. (D) Whole-cell lysates prepared from HEK-293 cells 
expressing URG7, MRP6102, SP-C(Val) and SP-C(Leu) with gGFP were subjected 
to Endo H digestion, SDS–PAGE and Western blot analysis. ●●● Denotes triply 
glycosylated form of MRP6102-gGFP, ●● doubly glycosylated form of SP-
C(Leu/Val)-gGFP, ● singly glycosylated form of URG7-gGFP and ○ non-
glycosylated form (Nout/Cin). M marks the standard molecular weight marker 





Figure 19. SP-C is inserted into the membrane in Nin/Cout orientation in vivo upon 
targeting to the membrane. (A) Whole-cell lysates prepared from HEK-293T cells 
expressing SP-C(Leu/Val)-N5-gGFP in the presence or absence of MG132 were 
subjected to Endo H digestion, SDS–PAGE and Western blot analysis. SP-
C(Leu/Val)-N5-gGFP contains an additional glycosylation site at the N-terminus 
compared to SP-C(Leu/Val)-gGFP used in Figure 17. for detection of proteins in 
Nout/Cin form. ●● Denotes a doubly glycosylated form (Nin/Cout) and ○ a non-
glycosylated form (Untargeted). * Denotes an unspecific band. (B) Schematic 
representation of SP-C biogenesis. Untargeted SP-C is degraded via the proteasome 





III.2. Structural profiling of the lateral gating helices of yeast Sec61 
III.2.1. The residues lining TMS7 of Sec61 affects the targeting and insertion 
of a single-spanning membrane 
To probe which residues in TMS2b and TMS7 of Sec61 are critical for the lateral 
gating function, systematic mutagenesis of these helices was performed. Residues 
82-99 in TMS2b and 290-308 in TMS7 were substituted with an Ala residue one at 
a time107. I specifically profiled the TMS7 residues of Sec61. 
First, the efficiency of targeting and membrane insertion of LepH1, a model single-
spanning membrane protein, was determined. The TMS was replaced with H-
segment of 5L/14A as it enables sensitive detection of the insertion efficiencies of 
Sec61 gate mutants. A plasmid encoding LepH1(5L/14A) was transformed into the 
Sec61 mutant strains, and each transformant was subjected to 5 min of S35Met 
radiolabeling and subsequent immuno-precipitation and analyzed by 
autoradiography (Figure 20A). The LepH1(5L/14A) segment is moderately 
hydrophobic and has 48% targeting efficiency (glycosylated products/total 
products) in WT Sec61107.  
Compared with WT, the targeting efficiency of the model protein was increased by 
10% for the I293A, F304A, and S307A Sec61 TMS7 mutants. Interestingly, in 
these mutants the model protein that was integrated into the membrane with an 
NinCout orientation was enhanced (45-54% in the mutants compared with 33% in 
WT) (Figure 20B). Another group of Sec61 mutants decreased the insertion of the 
Lep-H1 model protein. In Sec61 TMS7 mutants N290A, P292A, L295A, and 
N302A, 20% less of the LepH1 model protein was integrated into the membrane 
compared with WT. These mutations also decreased the relative amount of LepH1 
with an NinCout membrane topology






Figure 20. The targeting and membrane insertion of a single-spanning membrane 
protein in Sec61 gating helix mutants. (A) LepH1(5L/14A) model protein. H-
segment sequence with its apparent free energy of insertion (ΔG) is indicated. (B) 
WT cells expressing the model protein were radiolabeled with 35S Met for 5 min 
and subjected to immuno-precipitation and SDS-PAGE and analyzed by 
autoradiography. Before SDS-PAGE, one sample was split into two samples, one of 
which was treated with Endo H to remove all glycans. Different glycosylation 
states are indicated with closed circles. Open circle indicates an unglycosylated 
form. (C) Deviations of Lep-H1(5L/14A) membrane targeting efficiencies of the 
Sec61 mutant strains normalized to the WT level are plotted. The targeting 
efficiencies were calculated as the amount of glycosylated products over the total 
products. The average plus S.E. for at least three independent measurements is 
shown. (D) Relative amount (%) of Lep-H1(5L/14A) with an Nin-Cout membrane 
topology was calculated as 2G/(1G + 2G) × 100% using the same data set 
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in (B) and normalized against the WT level107.  
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III.2.2. The residues lining TMS7 of Sec61 affects the insertion of a 2nd TMS of 
a double spanning membrane protein 
The TMS in single-spanning membrane proteins initiates translocation, opens the 
Sec61 lateral gate, and positions itself in the NinCout or NoutCin orientation before 
membrane insertion. However, the mechanism of the membrane insertion of the 
downstream TMS in multi-spanning membrane proteins may differ because the 
initial opening of the channel is not required107.  
To test this, LepH2 model protein was used. LepH2 contains two hydrophobic 
segments with two N-linked glycosylation sites, one at the N terminus and the 
other at the downstream of the second TMS. The first TMS is the original first 
TMS of Escherichia coli Lep and is shown to efficiently target the protein to the 
ER69. The second segment was replaced by H-segment, consisting of 2L/17A (H2-
2L) or 3L/16A (H2-3L) (Figure 21A). We selected H-segments with 2L/17A and 
3L/16A, the H-segment membrane insertion efficiency of which are 20 and 70%, 
respectively.  
For WT and all the mutant strains, the model protein was efficiently targeted, as 
little unglycosylated products were detected. For H2-2L and H2-3L, compared with 
the WT level, I observed a group of mutations that decreased (N290A, P292A, 
L295A, S301A, N302A, and Q308A) the membrane integration of the H-segment 
(Figure 21 A, B). In the I293A and F304A Sec61 mutants, targeting and membrane 
insertion of the Lep-H1 protein were defective, but membrane insertion of the Lep-
H2 protein was only mildly impaired. In the S301A and Q308A Sec61 mutants, 
membrane insertion of the LepH2-3L model protein was reduced by 30% 
compared with the WT, whereas the targeting defect with the LepH1 model protein 
was moderate. It was noticed that the targeting and membrane insertion of LepH1 
was more severe in the TMS2b mutants compared with the TMS7 mutants. 
However, the membrane insertion of the H-segment in LepH2-3L construct was 
more severely affected in the TMS7 mutants than the TMS2b mutants. These 
results may indicate that the initial binding of a SAS may be mediated more by 








Figure 21. Membrane insertion of the second TMS of LepH2 model proteins in the 
Sec61 TMS2 and TMS7 mutants. (A) LepH2 has two potential TMS. H2-segment 
is shown as a blue rectangular box, and sequences with their apparent free energy 
of insertion (ΔG) are indicated. N-Linked glycosylation sites are indicated as Y, 
and occupied sites are shown with closed circles. Open and closed arrows indicate 
the cleavage sites for cleaved products, 1G* and 2G*, respectively. Cells were 
radiolabeled for 5 min with 35S Met, subjected to immuno-precipitation and SDS-
PAGE, and analyzed by autoradiography. Endo H treatment was carried out to 
remove all glycans before SDS-PAGE. Different glycosylation states are indicated 
with closed circles, including different cleaved products indicated with 
an asterisk (right). The open circle indicates an unglycosylated full-length protein 
that is untargeted. (B) H2-segment membrane insertion efficiency (%) was 
calculated as (2G + 2G*)/(1G + 2G + 1G* + 2G*) × 100% and normalized against 
the WT level. The average of at least three independent measurements plus S.E. is 
shown. (C) LepH2-2L and LepH2-3L were expressed in Sec61 WT and double 
mutant strains and analyzed as described in (A). H2-segment membrane insertion 
(%) was calculated as 2G/(1G + 2G) × 100%. (D) LepH2-5L was expressed in 
Sec61 WT and I83A/I91A double mutant cells. Cells were treated as in (A), and 
membrane insertion of H2-segment was calculated as in (B)107. 
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III.3. Profile of membrane protein insertion into mammalian ER 
III.3.1. Membrane insertion profile of single-spanning membrane proteins 
Unlike Saccharomyces cerevisiae where signal anchor proteins are targeted post- or 
co-translationally depending on the hydrophobicity of the SAS, a signal anchor 
protein targeting to the ER is shown to depend on the protein length in mammalian 
cells51,110.  
To study the targeting and insertion of signal anchor proteins in mammalian cells in 
greater detail, a set of LepH1 with variable hydrophobicity and C-terminal length 
were expressed in HEK-293T. The targeting of LepH1 was shown with H-segment 
with 3L/16A, and were inserted mainly in 1G form (NoutCin). The insertion profile 
was overall similar in HeLa and HEK-293T cells for LepH1 with a marginally 
hydrophobic SAS (Figure 22A). The more hydrophobic LepH1 with H-segment of 
7L/12A and 10L/9A were mainly inserted in 2G form (NinCout) in HeLa cells. 
However, the pulse labeling of LepH1 in HEK-293T revealed that 10L SAS is 
inserted in 1G form (NoutCin) (Figure 22B). Whether the differential insertion of 
LepH1-10L is a result of cell to cell variation (HeLa vs HEK-293T) or the protein 
detection technique (Western blotting vs pulse labeling) needs to be re-investigated. 
To confirm the glycosylation status of LepH1, Endo H digestion was performed. 
Strikingly, Endo H digestion revealed an Endo H sensitive product whose 
deglycosylated form was smaller than the non-targeted, unglycosylated full-length 
protein. The cleaved product was prevalent in LepH1 with a marginally 
hydrophobic TMS, 3L/16A to 6L/13A (Figure 22A, B). We speculate that LepH1 
with a marginally hydrophobic TMS is a substrate of signal peptidase complex 
(SPC) as LepH2 gets processed by SPC107. If the assumption is true and that the C-
terminal end of the TMS is cleaved, this implies that the majority of LepH1 is 
inserted as 2G form (NinCout) and is subsequently processed by SPC. In sum, 
LepH1 is primarily inserted in NinCout form, with an exception of LepH1-10L/9A in 
HEK-293T where the majority was inserted as NoutCin form. NinCout form is 
processed by SPC in hydrophobicity dependent manner, with a less hydrophobic 




Next, the truncated LepH1 composed of 121 amino acids were expressed in HEK-
293T to study the protein targeting by post-translational pathway. It is previously 
reported that polypeptides shorter than 120 amino acids are targeted post-
translationally in mammalian cells51. Just like the full-length LepH1, marginally 
hydrophobic signal anchors (5L/14A and 6L/13A) were cleaved whereas 
hydrophobic signal anchor (7L/12A) was not (Figure 22C). Thus, regardless of the 
targeting pathways, the topogenesis of signal anchor protein and the subsequent 
cleavage of SAS is unaffected. 
Lastly, the effect of the C-terminal length following the TMS on membrane protein 
topogenesis was examined. It was previously reported that a long C-terminal tail 
favors the protein topology of NinCout whereas a short C-terminal tail favors NoutCin 
orientation111. LepH1 fused to yeast gGFP was expressed in HeLa or HEK-293T. 
Yeast gGFP was non-functional in mammalian cells and thus regarded as an 
extension of the C-terminus112. Like full length LepH1 or truncated LepH1, the 
targeting to the ER was observed for LepH1 with 3L/16A H-segment (Figure 22D). 
However, the orientation of LepH1-gGFP relative to the membrane differed when 
expressed in HEK-293T, with the majority of LepH1-gGFP inserted in 1G form 
(NoutCin) regardless of the hydrophobicity (3L/16A to 7L/12A). No cleavage 
product was observed (Figure 22D, Middle). In contrast, LepH1-gGFP was cleaved 
efficiently when expressed in HeLa, and based on Endo H digestion analysis, 
LepH1-gGFP was inserted in NinCout form (Figure 22D, Bottom). The experiment 
needs to be repeated to confirm cell to cell variation. Based on the data obtained 
from HeLa cells, it is likely that the subsequent cleavage of LepH1 is independent 





Figure 22. The targeting and insertion of a single-spanning membrane protein in 
mammalian cells. LepH1 full length, truncated and gGFP tagged constructs were 
expressed in HeLa or HEK-293T. (A) Top. HeLa cells expressing LepH1 were 
lysed with NP-40, separated on SDS-PAGE, Western blotted and immuno-
decorated with α-HA. Middle. As in Top, but LepH1 was expressed in HEK-293T. 
Bottom. Endo H digestion of the samples from Middle. (B) Top. HEK-293T cells 
expressing LepH1 were pulsed labeled for 20 minutes, immuno-precipitated and 
subjected to autoradiography. Bottom. Endo H digestion of the samples from Top. 
(C) As in (A) Top, except that the expressed construct is the truncated LepH1 (H1-
120). The schematics of LepH1 full length, truncated and gGFP tagged constructs 
are depicted. (D) As in (A), except that the expressed construct is LepH1-gGFP. ○ 




III.3.2. Membrane insertion profile of multi-spanning membrane proteins 
To investigate the insertion of multi-spanning membrane proteins, LepH2 and 
LepH3 were expressed in HEK-293T. LepH2 is a double spanning membrane 
protein and has a test segment composed of n-leucine and 19-n alanine as the 2nd 
TMS. LepH3 has one more TMS when compared to LepH2 and has a test segment 
as the 3rd TMS. The insertion of the test segment is monitored by the glycosylation 
status, with LepH2 being singly glycosylated (1G) when the test TMS is non-
inserted and doubly glycosylated (2G) when inserted. For LepH3, it is 2G when the 
test TMS is non-inserted and 1G when inserted (Figure 23A). 
LepH2 with a test segment of 2L/17A and 3L/16A were efficiently targeted to the 
ER, inserted into the membrane and cleaved efficiently (Figure 23A). In 
comparison, LepH1-2L could not be targeted/inserted into the ER membrane. This 
agrees with the previous report that once the protein is targeted to the ER, the 
hydrophobicity required for the insertion of a downstream TMS is not high107,109. 
Pulse labeling revealed that the cleavage of LepH2 occurs in time dependent 
manner (Figure 23B). When cells expressing LepH2 were labeled for 5 minutes, no 
cleavage product was observed for LepH2-2L and a little for LepH2-3L. However, 
when the cells were labeled for 20 minutes, more than half of membrane inserted 
proteins (2G forms) were cleaved (Figure 23B). 
LepH3 with a test segment of 19L efficiently targeted to the ER and inserted into 
the membrane. However, LepH3 with a test segment of 3L/16A or 5L/11A were 
efficiently targeted to the ER, but the insertion of the test segments into the 
membrane were very poor (Figure 23C, D). In comparison, a test segment with 
2L/17A was efficiently inserted into the membrane when placed in the context of 
LepH2 (Figure 23A, B). As the key difference between LepH2 and LepH3 is the 
number of TMS which makes the orientation of the test segment different upon 
membrane insertion, the results suggest that the hydrophobicity required for a TMS 
insertion is much lower when the insertion occurs in NinCout orientation (as in 





Figure 23. The insertion of 2nd or 3rd TMS into the membrane. LepH2 and LepH3 
were expressed in HEK-293T. (A) Left. Schematics of LepH2. Right. HEK-293T 
cells expressing LepH2-2L or 3L were lysed with NP-40, separated on SDS-PAGE 
and immuno-decorated with α-HA. (B) Left. HEK-293T cells expressing LepH2-
2L or 3L were pulsed labeled for 5 minutes, immuno-precipitated and subjected to 
autoradiography. Right. Endo H digestion of 20 minute pulse labeled LepH2-3L 
from HEK-239T cells. (C) Top. Schematics of LepH3. Bottom. HEK-293T cells 
expressing LepH3-3L, 5L or 19L were lysed with NP-40, separated on SDS-PAGE, 
Western blotted and immuno-decorated with α-HA. (D) Left. HEK-293T cells 
expressing LepH3-3L, 5L or 19L were pulsed labeled for 20 minutes, immuno-
precipitated and subjected to autoradiography. Right. Endo H digestion of the 




Membrane insertion of a TMS may differ for a TMS that is found in the midst of a 
multi-spanning membrane protein than a TMS that serves as the last TMS. To test 
this, LepIV and LepV, which span the membrane four and five times with the test 
segment in the 3rd and 4th TMS respectively, were expressed in HEK-293T. The test 
segment is inserted in NoutCin in LepIV and NinCout in LepV (Figure 24). 
This case, unlike LepH2 and LepH3, the orientation of the test TMS did not have a 
significant influence on the threshold hydrophobicity for membrane insertion. Up 
to 4L/15A, the membrane insertion efficiency of the test TMS was low and 7L/12A 
was required for an efficient insertion both for LepIV and LepV (Figure 24).  
To study the insertion of the test segment in the absence of the last TMS, LepIV 
and LepV were truncated (LepIV TC and LepV TC, respectively). Membrane 
insertion of the test segment was complete with 7L/12A in both cases, and partial 
with 4L/15A test segment (Figure 25). Again the insertion of the 4L/15A test 
segment was more efficient in LepV TC where the test segment insertion occurs in 
NinCout compared to LepIV TC where the test segment insertion occurs in NoutCin. 
This is in agreement with the previous observation with LepH2 and LepH3. 
In sum, the insertion of the last TMS occurs more efficiently than the TMS that 
precedes the last TMS for unknown reasons. For the insertion of the last TMS of a 
multi-spanning membrane protein, the insertion in NinCout requires less 
hydrophobicity than insertion in NoutCin form. The experiments need to be repeated 





Figure 24. The insertion of a TMS in the middle of multi-spanning membrane 
proteins. LepIV and LepV were expressed in HEK-293T. (A) Top. Schematics of 
LepIV. Middle. HEK-293T cells expressing LepIV-2L, 4L or 7L were lysed with 
NP-40, separated on SDS-PAGE, Western blotted and immuno-decorated with α-
HA. Bottom. Endo H digestion of the samples from middle. (B) Top. HEK-293T 
cells expressing LepIV-2L, 4L or 7L were pulsed labeled for 20 minutes, immuno-
precipitated and subjected to autoradiography. Where indicated Endo H digestion 
was performed. Bottom. The same as in Top. Endo H untreated samples were run 
side by side for size comparison. (C) Top. Schematics of LepV. Middle. HEK-293T 
cells expressing LepV-1L, 4L or 7L were lysed with NP-40, separated on SDS-
PAGE, Western blotted and immuno-decorated with α-HA. Where indicated, Endo 
H digestion was performed. (D) The same as in (B) except that the expressed 




Figure 25. The insertion of 3rd or 4th TMS. LepIV-TC and LepV-TC were 
expressed in HEK-293T. (A) Top. Schematics of LepIV-TC. Bottom. HEK-293T 
cells expressing LepIV-TC-2L, 4L or 7L were lysed with NP-40, separated on 
SDS-PAGE, Western blotted and immuno-decorated with α-HA. Endo H was 
treated where indicated. (B) HEK-293T cells expressing LepIV-TC-2L, 4L or 7L 
were pulsed labeled for 20 minutes, immuno-precipitated and subjected to 
autoradiography. Where indicated Endo H digestion was performed. (C) Top. 
Schematics of LepV-TC. Bottom. HEK-293T cells expressing LepV-TC-4L or 7L 
were lysed with NP-40, separated on SDS-PAGE, Western blotted and immuno-
decorated with α-HA. Where indicated, Endo H digestion was performed. (D) The 
same as in (B) except that the expressed model proteins are LepV-TC-4L and 7L. ○ 





III.3.3. siRNA mediated silencing of Sec62 
To functionally characterize the subunits of the mammalian SEC61 complex, 
siRNA mediated knock down of individual subunits was designed. The scheme was 
to deplete the target component of SEC61 by siRNA followed by transient 
expression of a model membrane protein. The insertion of a model membrane 
protein in the absence of the chosen subunit of SEC61 would uncover the role of 
the silenced subunit in membrane protein biogenesis. 
As a starting point, Sec62 silencing was attempted. Sec62 was reported to facilitate 
the C-terminal translocation of a marginally hydrophobic TMS of membrane 
proteins in yeast16,17. To figure out whether the Sec62’s role is conserved in 
mammalian cells, siRNA targeting the untranslated region (UTR) of SEC62 mRNA 
were introduced into cells and the silencing was monitored by Western blotting 
with Sec62 and GAPDH antibodies (control). 70% silencing efficiency (the 
amounts of Sec62 normalized by GAPDH were compared) was achieved when the 
cells were incubated with 50 nM siRNA for 48 hours (Figure 26). Transfection of a 
model protein at 48 hour-time point is required to observe the effect of Sec62 
silencing. 
 
Figure 26. Sec62 knock down. HEK-293T were transfected with a scrambled 
siRNA (negative control) or siRNA targeting SEC62 mRNA. The cells were 
maintained for 48 hours after transfection and lysed with NP-40. Cell lysates were 
analyzed by SDS-PAGE and Western blotting. Sec62 and GAPDH were detected 





III.3.4. Rescue of Sec62 knock-down 
Although a negative control siRNA was used, the possibility of an off-target effect 
by SEC62 siRNA still existed. To confirm that the observed phenotype was a direct 
consequence of Sec62 silencing, a rescuing experiment was designed. 
Here, after the silencing of Sec62 by transfection of siRNA targeting the UTR of 
SEC62, a plasmid encoding cDNA of SEC62 would be transfected. Total RNA 
extracted from HEK-293T was used to make cDNA library and SEC62 was 
amplified using gene specific primers. The cDNA of SEC62 was subsequently 
cloned into pcDNA 3.1 plasmid. The rescue of the observed defect by the 
expression of SEC62 from the plasmid would rule out the off-target effect. 
The designed rescuing scheme also enables the identification of an active domain 
of Sec62 involved in membrane protein biogenesis by systematic mutagenesis on 
cDNA of SEC62. The mutant Sec62 that is incapable of rescuing the defect would 
highlight the key domain of Sec62. 
 
III.3.5. Expression of human translocon subunits in yeast 
Mammalian SEC61 complex has more subunits compared to yeast SEC61, yet 
most studies on SEC61 complex were done in yeast due to the ease of genetic 
manipulation. 
In the thesis, rescue of the SEC61 subunit deletion strains of Saccharomyces 
cerevisiae were attempted by the expression of mammalian homologues. The 
complementation assay would provide a direct evidence of a conserved function of 
proteins. SEC61α, SEC62 and TRAM1 were amplified from cDNA library and 
cloned into p424GPD vector by homologous recombination. Due to time 




III.4. Lateral gating of TIM23 by Mgr2 is limited to Mgm1 and 
Cyb2 
III.4.1. Expression level of Mgr2 is low 
Mgr2 was shown to regulate the membrane insertion of Mgm1 and Cyb2. Thus, it 
was proposed as a lateral gate keeper of the TIM23 complex104. To study the role of 
Mgr2 in the gate keeping of TIM23 complex, Mgr2 deletion (mgr2Δ), Mgr2 
overexpression (Mgr2↑) and the corresponding WT strain were obtained from Dr. 
Pfanner104. To confirm the strains, cells were cultured in a fermentable carbon 
source (glucose) and the proteins were prepared for Western blotting. Mgr2 was 
properly overexpressed in Mgr2↑, however, the endogenous Mgr2 was barely 
detectable in WT strain (Figure 27A). WT and mgr2Δ strains were further 
confirmed by PCR. 
Mitochondrial health is at optimum when cells respire. To check the expression of 
Mgr2 at optimal mitochondrial health, cells were grown in non-fermentable carbon 
source (glycerol) and the proteins were prepared for Western blotting. However, the 
expression level of Mgr2 remained low and was indifferent from the cells grown in 
fermentable carbon source (Figure 27B). Thus, Mgr2 is expressed at a low level in 
Saccharomyces cerevisiae regardless of the carbon source. 
 
Figure 27. Mgr2 expression in WT, mgr2Δ and Mgr2↑. (A) Proteins were TCA 
precipitated from overnight cultures of WT, mgr2Δ and Mgr2↑ in glucose. Proteins 
were separated on 16% Tricine gel to distinguish 16kDa preMgr2 from 9kDa Mgr2. 
The protein bands were detected using α-Mgr2. (B) The same as in (A) except that 
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the cells were grown in glycerol and the proteins were separated on 15% Tris-Cl 
gel. WT, Wildtype; Δ, mgr2Δ; ↑, Mgr2↑.   
64 
 
III.4.2. Mgr2 does not set the hydrophobicity requirement for membrane 
protein insertion into mitochondrial IM 
To test whether Mgr2 sets the hydrophobicity requirement for membrane protein 
insertion into IM, a set of Mgm1 whose 1st TMS is replaced by 19 alanine/leucine 
stretch (Mgm1-A/L) was expressed in WT, mgr2Δ and Mgr2↑. If Mgr2 acts as a 
lateral gate keeper, the overexpression of Mgr2 would increase the protein 
translocation (i.e. decrease the insertion) whereas the absence of Mgr2 would have 
an opposite effect. However, no significant difference was observed in membrane 
protein translocation efficiency in three strains monitored by the amount of s-
Mgm1 regardless of the hydrophobicity of the tested TMS (Figure 28A, B). Thus, 
Mgr2 does not appear to set the hydrophobicity required for the membrane protein 
insertion into mitochondrial IM. 
 
Figure 28. No difference in the membrane insertion of Mgm1 carrying varying 
hydrophobicity among WT, mgr2Δ and Mgr2↑ strains. (A) Mgm1-A/L with 
indicated L were expressed in WT, mgr2Δ and Mgr2↑. Proteins were TCA 
precipitated from overnight cultures in glucose. Proteins were separated on 6.5% 
Tris-Cl gel to distinguish l-Mgm1 and s-Mgm1. The protein bands were detected 
using α-HA. (B) The quantification of s-Mgm1 from (A). WT, Wildtype; Δ, mgr2Δ; 
↑, Mgr2↑.   
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III.4.3. Mgr2 does not affect the sorting of mitochondrial IM proteins taking 
the stop-transfer or conservative sorting pathway 
Mgm1-A/L is dislocated from the mitochondrial IM by the mAAA protease102. To 
rule out the effect of the mAAA protease and to determine if Mgr2 affects insertion 
of other mitochondrial IM proteins, MFPs taking the stop-transfer pathway and 
conservative sorting pathway were selected114. The selected MFPs were derived 
from native IM proteins and were previously shown to be uninfluenced by the 




Table 1. The ΔG values of the 1st TMS of MFPs taking the stop-transfer pathway 
(left) and conservative sorting pathway (right). ΔG values of Mgm1-A/L for 
comparison. The TMS of stop-transfer proteins are in general more hydrophobic 




The hypothesis was that the insertion of stop-transfer proteins would be reduced by 
Mgr2 overexpression due to the jamming of the lateral gate of the TIM23 complex. 
On the other hand, the translocation of conservative sorting proteins would be 
reduced by Mgr2 deletion as the lateral gate remains unoccupied with Mgr2, 
therefore probably remains in an open conformation which may favor the insertion 
of conservative sorting proteins. However, the sorting of stop-transfer proteins into 
IM was unaltered by Mgr2 overexpression as evident by the generation of l-MFPs 
(Figure 29A). The sorting of conservative sorting proteins to the matrix was also 
unaffected by Mgr2 deletion (apart from Yta10-MFP which was sorted into the 
membrane regardless of Mgr2 level) (Figure 29B). In sum, Mgr2 has negligible 
effect on the insertion of mitochondrial IM proteins regardless of the sorting 
pathway. 
 
Figure 29. The membrane insertion of MFPs is unaffected in WT, mgr2Δ and 
Mgr2↑. (A) MFPs taking the stop-transfer pathway were expressed in WT, mgr2Δ 
and Mgr2↑. Proteins were TCA precipitated from overnight cultures in glucose. 
Proteins were separated on 6.5% Tris-Cl gel to distinguish l-MFPs and s-Mgm1. 
The protein bands were detected using α-HA. (B) The same as in (A) except that 
the expressed proteins take conservative sorting pathway. WT, Wildtype; Δ, mgr2Δ; 
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↑, Mgr2↑; *, non-specific.  
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III.4.4. Mgr2 senses the charges preceding the TMS of Mgm1 
The sorting of Mgm1-A/L and MFPs were not influenced by the Mgr2 expression 
level. This led to a new hypothesis that Mgr2’s function may be specific to 
previously tested proteins, Mgm1 and Cyb2104. To confirm this, Mgm1 and Cyb2 
were expressed in WT, mgr2Δ and Mgr2↑. Membrane insertion of Mgm1 (l-Mgm1) 
was reduced by Mgr2 overexpression (Figure 30A). Surprisingly, in this study, 
Mgr2 deletion did not increase the amount of l-Mgm1. This could be due to the low 
expression level of Mgr2 in WT making it indistinguishable from mgr2Δ. The 
sorting of Cyb2 was analyzed by Western blotting assay. The processing of Cyb2 
monitored by the band size was unaltered regardless of Mgr2 level, however the 
overall expression level of Cyb2 was affected (Figure 30B). Cyb2 expression was 
at the highest in the absence of Mgr2 and lowest upon overexpression of Mgr2. A 
detailed analysis with a control protein is needed to confirm the observation. 
 
Figure 30. Mgr2 affects the sorting of Mgm1. (A) Mgm1 was expressed in WT, 
mgr2Δ and Mgr2↑. Proteins were TCA precipitated from overnight cultures in 
glucose. Proteins were separated on 6.5% Tris-Cl gel to distinguish l-Mgm1 and s-
Mgm1. The protein bands were detected using α-HA. (B) The same as in (A) 





The sorting of Mgm1’s 1st TMS is heavily dependent on the flanking charged 
residues115. As Mgr2 was previously reported to block the insertion of Cyb2 with 
mutated N-terminal flanking charges, I hypothesized that Mgr2 recognizes the 
charged residues that flanks the TMS of Mgm1104. 
To test this, the sorting of mutant Mgm1 proteins were analyzed in WT, mgr2Δ and 
Mgr2↑. The mutations either replaced the charged residues to neutral residues or 
the residues of opposite charges. Mutations at the N-terminus of Mgm1 resulted in 
Mgr2 independent sorting, with the exceptions of R78A, R78AR79A GGM:VVL 
mutations (Figure 31A). However, the mutations of the C-terminal flanking 
charged residues did not change the Mgm1 sorting dependency on Mgr2 (Figure 
31B). This suggests that the charged residues that flanks the matrix side of the 
TMS of Mgm1 plays a key role in Mgr2 regulated Mgm1 insertion into the 
membrane. This is in great agreement with the previous observation that the 
mutations of the sorting signal composed of two charged residues at the matrix side 
is recognized by Mgr2104. In addition, the overall expression level of Mgm1 
variants was affected. Like Cyb2, the expression was at lowest upon 
overexpression of Mgr2 (Figure 31A, B). Again, detailed analysis with a control 





Figure 31. Mgr2 senses the flanking charged residues of Mgm1. (A) The N-
terminal flanking charged mutants of Mgm1 were expressed in WT, mgr2Δ and 
Mgr2↑. Proteins were prepared and separated as described in Figure 25. (B) The 
same as in (A) except that the expressed protein were the C-terminal flanking 
charged residues. WT, Wildtype; Δ, mgr2Δ; ↑, Mgr2↑, *, non-specific. 
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III.4.5. Mitochondrial IM protein sorting in glycerol is unaffected by Mgr2 
Membrane potential affects the mitochondrial protein import and strong membrane 
potential is built across the mitochondrial IM when the cells are forced to respire in 
non-fermentable carbon source medium138. To test whether the Mgr2’s role in 
regulating the protein entry into the mitochondrial IM is pronounced upon 
respiration condition, the sorting of a selected MFPs, Mgm1-WT and Mgm1 
flanking charged mutants were tested in WT, mgr2Δ and Mgr2↑. The sorting of all 
tested proteins in glycerol media were unaffected by Mgr2 expression level (Figure 
32). Thus, this further confirms that Mgr2 does not regulate all of mitochondrial IM 
protein insertion, rather its role is limited to Mgm1 and Cyb2. 
 
 
Figure 32. Mitochondrial IM protein sorting in glycerol is unaffected by Mgr2 
expression level. The sorting of Mrs2-MFP, Tcm62-MFP, Dld1-MFP, Mgm1-WT, 
Mgm1-R78A, Mgm1-R78A R79A GGM:VVL, Mgm1-K112AE114AE115A and 
Mgm1-E114KE115K were tested in WT, mgr2Δ and Mgr2↑ cultured in glycerol. 





III.4.6. Sorting kinetics of mitochondrial IM proteins. 
In the previous study, the sorting of Cyb2-DHFR into the mitochondrial IM was 
delayed upon overexpression of Mgr2 and facilitated in the absence of Mgr2104. 
Western blot gives the homeostatic levels of proteins and is incapable of providing 
the sorting kinetics. Thus, pulse-chase experiment was done for Mgm1-R78A to 
analyze the protein sorting during the early biogenesis step. Here, the 
overexpression of Mgr2 delayed the generation of s-Mgm1. It took 20 minutes 
after the initial pulse labeling to reach about 50% of s-Mgm1 (Figure 33). Thus, 
Mgr2 delays the sorting of proteins to the membrane at least for Mgm1. The sorting 
kinetics of other MFPs will be tested in the near future. 
 
 
Figure 33. The differential sorting of Mgm1-R78A in WT, mgr2Δ and Mgr2↑. 
Yeast transformants expressing Mgm1-R78A was pulsed labeled for 10 minutes at 
30° C and chased for 10, 20 or 40 minutes. The samples were immuno-precipitated 
and subjected to autoradiography. An unknown band, marked as *, was detected in 
between l-Mgm1 and s-Mgm1 and was evident in Mgr2↑.  
73 
 
III.5. TIM23 mutagenesis screening 
III.5.1. Validation of TIM23 mutagenesis selection scheme 
The selection scheme described in I.4.4. was validated by the growth assay. cyc3Δ 
did not grow on non-fermentable carbon source. The growth defect was recovered 
by expressing CYC3, CYC3HA and preCyb2-CYCHA but not with an empty 
vector or a vector encoding preCyb2(A63P)-CYC3HA (Figure 34). The same result 
was obtained for tim23Δcyc3Δ[pRS316TIM23]. As preCyb2-CYC3HA supports 
the growth once it is in the membrane, the transformants expressing 
preCyb2(A63P)-CYC3HA, in theory, is capable of growing on non-fermentable 
carbon source if there exists a mutant Tim23 that is capable of inserting the fusion 





Figure 34. Validation of TIM23 random mutagenesis screening. (A) Yeast strain 
(cyc3∆) was transformed with an empty plasmid or a plasmid encoding CYC3, 
CYC3HA, preCyb2-CYC3HA or preCyb2(A63P)-CYC3HA. The yeast 
transformants were streaked on YPEG (non-fermentable carbon source) and 
incubated at 30℃ for two days. cyc3∆ did not grow on YPEG. The growth defect 
was rescued by expression of CYC3, CYC3HA and preCyb2-CYC3HA. The 
expression of preCyb2(A63P)-CYC3HA did not rescue the growth defect, 
indicating that the fusion protein was translocated to the matrix. (B) The summary 

















IV.1. Development of an ER topology reporter 
IV.1.1. gGFP as a novel ER topology reporter of eukaryotic cells 
Membrane proteins function as transporters or signaling receptors and carry out 
vital cellular processes7. Obtaining the structure of membrane proteins has always 
been important to understand the function of proteins and to design appropriate 
drugs that target them. Yet, most membrane proteins lack the structural information 
due to the experimental challenges in overexpression, crystallization14.  
In this thesis, gGFP that fluoresces in the cytosol but becomes glycosylated and 
non-fluorescent in the ER lumen, was developed as a eukaryotic topology reporter 
and used to validate NoutCin topology of URG7, NoutCout of MRP6 and NinCout of 
SP-C106,112. gGFP is advantageous over many of the previously used topology 
reporters, such as FPP assay, as it allows rapid fluorescence based live-cell 
assessment of membrane protein topology without the need of cell fixation or lysis. 
In addition, the glycosylation status of gGFP not only serves as a back to back 
control assessment of membrane protein topology, but also rules out the possible 
misinterpretation of the fluorescence based assessment that arises from partial 
targeting of membrane proteins, proteins of mixed topology or low expression of a 
fusion protein. However, it should be noted that the use of gGFP is limited to the 
ER targeted membrane proteins as N-linked glycosylation is specific to the ER. 
The developed gGFP offers a new tool to facilitate the topology determination of 
ER membrane proteins in vivo and has potential to be used in global screening of 
ER membrane protein topology. 
IV.2. Protein insertion into the ER membrane by the SEC61 
complex 
IV.2.1. The role of lateral gating helices of Sec61 in membrane protein 
insertion  
Next, Sec61, the pore forming subunit of the SEC61 complex, was characterized 
by systematically replacing the residues lining TMS2 and 7 to an alanine residue. 
TMS2 and 7 of Sec61, termed as the lateral gating helices, opens laterally towards 
the membrane to allow partitioning of a TMS63-65. The mutagenesis screening 
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classified residues into two groups, the ones that enhance membrane protein 
insertion and the others that impair it107. The importance of the lateral gating 
helices in mediating membrane protein insertion were highlighted in the previous 
studies, where the pore ring residues and several residues of the lateral gating 
helices were reported to fine tune the threshold hydrophobicity for membrane 
protein insertion and influence topogenesis. Compared to the previous studies, this 
study provided the first extensive screening of the entire lateral gating helices. The 
fact that the several residues identified in this study, such as P292 and N302, 
overlap with the previously reported phenotypes in regulating membrane protein 
insertion ensures the sensitivity and reliability of the screening. In addition to the 
systematic grouping lateral gating residues into two groups, TMS2 affected the 
insertion of signal anchor proteins to a greater degree whereas TMS7 affected the 
insertion of multi-spanning membrane proteins more. These observation suggest a 
model where TMS2 plays a role in the initial opening of the channel and TMS7 
governs the insertion of downstream TMS.  
IV.2.2. A platform to study the SEC61 complex mediated membrane protein 
insertion in mammalian cell-lines 
To explore the mammalian SEC61 complex, the targeting and topology profile of a 
set of model membrane proteins used in yeast system were examined. Here, the 
signal anchor proteins were targeted with 3 leucine, similar to yeast, but were 
cleaved more efficiently in mammalian cells. In addition, the hydrophobicity 
required for the insertion of 2nd TMS was also lowered in mammalian cells. The 
differences may be attributable to the subunits of the SEC61 complex specific to 
the mammalian cells such as TRAM or TRAP. This study provides a platform to 
monitor the model membrane protein insertion profile in the mammalian cells 
lacking a specific SEC61 complex subunit, thereby identifying the role of such 
subunits in mammalian cells. Understanding the mammalian SEC61 translocon 
complex is important for numerous reasons. For about 30% of proteins, they are 
initially targeted to the ER during the biogenesis en route to the secretory pathway 
and their translocation across or insertion into the ER membrane is mediated by the 
SEC61 translocon complex34,35,40,41. Moreover, failures in the proper assembly of 
the translocon complex is devastating. It leads to defects in protein secretion which 
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in turn raises several health issues including digestion problems and diabetes. In 
addition, mutations in the components of the translocon have been linked to several 
physiological diseases139. For instance, overexpression of Sec62 and Sec63 is 
observed in various cancer cells. Sec63 is also mutated in polycyctic liver diseases. 
One of the nucleotide exchange factors, Sil1, which assists BiP during protein 
import, is linked to neurodegeneration140. Further studies with a collection of 
translocon subunit knock-out cell lines are needed to reveal the roles of different 
subunits of SEC61 complex in targeting and topogenesis of membrane proteins. 
IV.3. Protein insertion into the mitochondrial IM by the TIM23 
complex 
IV.3.1. Mgr2 may not act as a general gate keeper of the TIM23 complex 
Lastly, the key factors that regulate the TIM23 complex mediated entry of 
mitochondrial IM proteins into the IM, with specific emphasis on the role of Mgr2 
was examined. Mitochondrial IM is the protein richest membrane in cells and 
governs respiration141. Several metabolic disorders and neurodegenerative diseases 
have been linked to mitochondrial dysfunction142. The proper assembly of IM 
proteins is crucial for optimal mitochondrial health, yet, how IM proteins are 
recognized by TIM23 complex and inserted into the membrane remain unanswered. 
Recently, Mgr2 was assigned as a lateral gate keeper of the TIM23 complex as the 
sorting of Mgm1 and Cyb2 into the membrane was delayed upon overexpression of 
Mgr2 and facilitated upon deletion104. However, when the insertion of other IM 
proteins was tested in this thesis, their insertion was uninfluenced by Mgr2 levels. 
In addition, the hydrophobicity required for a TMS insertion into mitochondrial IM 
remained unchanged. This may be due to the low endogenous expression level of 
Mgr2 in cells. The fact that endogenous Mgr2 is barely detectable in cells suggests 
that not all of the TIM23 complex contain Mgr2, therefore for most mitochondrial 
proteins, Mgr2 may not be required. In addition, for Mgm1, the substrate of Mgr2, 
its 1st TMS is unique in a sense that it has a boarder lining features for its insertion 
into the IM with 50% insertion efficiency. This suggests that Mgr2 may only be 
required for such proteins where the protein insertion efficiency need to be tightly 
79 
 
regulated. In sum, it seems that Mgr2’s role in gate keeping of TIM23 complex is 
limited to Mgm1 and Cyb2.  
IV.3.2. The molecular mechanism of the TIM23 complex mediated protein 
import and insertion into the membrane 
To further identify the mechanism of TIM23 mediated membrane protein insertion, 
a genetic screening was devised and validated to select for Tim23 mutants that is 
capable of inserting a TMS with a proline. A TMS with a proline is frequently 
found in conservatively sorted proteins and these TMS escape the recognition by 
the TIM23 complex, but how the TIM23 complex discriminates a TMS with a 
proline is unknown103. Thus, uncovering the domain of Tim23 that distinguishes 
the TMS of stop-transfer and conservative sorting is the first step towards 
understanding the TMS recognition by TIM23, hence mechanism of membrane 
protein insertion into the mitochondrial IM. In addition, information on speed and 
forces that act on a polypeptide during the import into mitochondria have not been 
quantitatively analyzed. As the quantitative analysis of the import process is 
difficult in vivo, an optical tweezer based in vitro protein import assay was 
designed. The kinetics and the forces will be recorded by tracking a single protein 
import into isolated mitochondria with different force loaded. This experimental 
setup is expandable to monitor the protein import speed upon various stress 
conditions or different presequence. The proposed studies will shed light on the 
molecular mechanism of mitochondrial protein import by providing a numerical 
data of kinetics and forces. 
In sum, this thesis attempted to provide a novel tool to solve membrane protein 
topology and resolve the molecular mechanism of translocon mediated membrane 
protein insertion at the ER and mitochondrial IM. Follow-up studies will solve the 
previously unreported topology of membrane proteins, the domains responsible for 
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진핵 포에  translocon  통한 
막단 질  삽 과  연  
헌상 
울 학  연과학 학 생 과학  
막단 질  체 단 질   30% 도  차지하고 는 단 질  
 주   고, 신 달과 질수  등  다 한 역할  
수행한다. 라  막단 질   는 것  막단 질  역할에 
한 연  신  개 에 어 가  한 지만 다수  
막단 질 는 직 규 지 못하 다. 는 막단 질  는 
 필 한 다 한 실험  재  막단 질 결  과 에  
어 움에  한다. 
여러 생 보학 프 그램들  통해 막단 질  2차  상  
측할 수 나, 는 결  포 내에  실험  어  한다. 
그러나 그 동  살 는 진핵 포 내에  단 질 상  결  
실험  재  해 가능하 다.  에 는 새 운 상 
 결    동  포에  가능한 리코실  색 
 단 질 (glycosylatable green fluorescent protein, gGFP)  
개 하 다. gGFP는 단 근처에  개  리코실  리  가지고 
어 포질에 는 리코실 지 고  하지만 포체 
내에 는 리코실 고  사라진다. 그러므  리코실  에 
  하여 gGFP  포 내 치  직  찰할 수 
다.  에 2차 가 진 막단 질  카 복시 말단에 
gGFP  착하여 상  결   gGFP  가  
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하 다. 나 가 간 질병과 연  3가지  막단 질, Urg7, Mrp6, 
SP-C  상  결 하 다. 가  수  SP-C는 못  
향  삽  지만 못 삽  SP-C는 시 프 에 해 
해 다는 것  찰하 다. 결  gGFP는 빠 고 하게 
막단 질 상  살 는 포 내에  찰할 수 는 새 운 다. 
막단 질  상  생 단계에  결 다. 막단 질  막에 재하는 
단 질 달 통  복합체  통하여 막에 삽 다. 단 질 달 통  
복합체  단 들    지만, 것들  어떻게 막 통  
식하여 특  상  삽 시키는지는 직  지지 다. 
그리하여  에 는 포체  미 콘드리  내막에  단 질 달 
통  복합체에 한 막단 질 삽 과   연 하 다. 
포체 막  막단 질 삽  SEC61 복합체에 해 루어진다. 
막단 질 삽  해 Sec61   째  곱 째 막 통  사  
(측  통 )  열린다. Sec61 변 들  한  연 들  막단 질 
삽  과  단순한 열역학  상  닌 Sec61에 한 능동  삽  
과  미했다. Sec61 측  통 가 어떻게 열리고 닫 는지에 한 
한  연  해 Sec61   째  곱 째 막 통  
미 산  하나  변 시킨 후  내에   단 질  상 변  
찰하 다.  연  결과  탕  Sec61 변 들  열린 체  
가지는 집단과 닫  체  가지는 집단  하 는 , 단  막 
통 단 질  삽   째 막 통  변  들에   
향  는  다  막 통 단 질  경우에는 곱 째 막 
통  변  들에   향  는다는 것  찰하 다. 
합   연 는 포체  막단 질 삽 과 상 결 에 





동  포  SEC61 복합체에는 에는 없는 가  단 들  
재한다.  에 는 SEC61에 한 연  동  포  시키  
하여,  각각  단 들  역할  하여 에  쓰  
단  막 통 단 질과 다  막 통 단 질들  HEK-293T  HeLa 
포에 시켰다. 복합 막 통 단 질  경우, 막 삽  한 역치 
수  에 비해 동 포에   낮  찰했다. 가  
간  수  띤 단  막 통 단 질  경우 동  포에  린 
태가 가하 다. 러한 동  포에  생하는 포체  
막단 질 삽  과   해하  해 는 각각  SEC61 
복합체  단  없 거나 변 시킨 후 단 질 삽  과  어떻게 
변하는지  보는 후  연 가 필 하다. 
미 콘드리  내막  단 질 삽  주  TIM23 복합체에 해  
루어 진다. SEC61 복합체  경우  달리 TIM23 복합체는 진 
측  통 가 없었 나 근 TIM23 복합체  단  Mgr2  에 
라 내막 단 질  Mgm1과 Cyb2  막 삽 과  지연 는 진 
다는 것  다.  해 Mgr2는 TIM23 복합체  측  통  
개폐  었다.  에 는 Mgr2가 다  막단 질  삽  
과 에도 향  미치는지,  그 다  Mgr2가 미 콘드리  
내막  막단 질 삽 에 필 한 수  역치  결 하는지  
연 하 다. Mgr2  량  미 콘드리  내막  단 질 삽 과 
에 필 한 수 에  향  주지 못함에 라 Mgr2  측  
통  개폐  역할  Mgm1  Cyb2  같  단 질에 특 어 
 하 다. 
TIM23 복합체  통해 삽 는 막단 질들  크게 결 동 경  
는 보   경  다. 결 동 경  단 질들  TIM23 
복합체에 해 직  막  삽  는 , 보   경  
단 질들  질   수  후 내막  삽 다. 생 보학  
 보   경  단 질  막 통 에  프 린 미 산  
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하게 견 다는 것  내었다.  결과  탕  본 에 는 
Tim23가 어떻게 막 통  프 린 미 산  식하고 질  
하는지  연 하  하여 계   변  검사   
 변  검사  계하 다. 는 막 통  프 린 미 산에 
한 항  가진 Tim23 변  찾 내  한 것 다. 가  
미 콘드리  단 질 수  도  그  측 할 수 는  집게 
 계하 다.  에  계  연 들  미 콘드리 에  
단 질 수 과 내막  삽 는 과 에 한  단  해  
도울 것 다. 
주  단어: 막단 질, 상, 색  단 질, 리코실 , 포체, 
미 콘드리 , 단 질 달 통  복합체. 
학 : 2010-20330 
 
